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ABSTRACT
Lisa M. Antoszewski: Regulation of E2f1-target gene expression during Drosophila
embryogenesis
(Under the direction of Robert J. Duronio)
Cell proliferation is tightly controlled during animal development, and a key aspect of
this control is cell cycle exit prior to terminal differentiation. Since most cells exit the cell
cycle during G1, it is important to understand how the activities of the transcription factors
and Cyclin/Cyclin-dependent kinase (Cyc/Cdk) complexes that promote S phase entry are
restrained. In this thesis, I used both genetic and cell biological tools to examine the
mechanisms of G1 cell cycle exit during embryogenesis in Drosophila melanogaster.
In the Drosophila embryo, G1 arrest first appears in epidermal cells during mid-
embryogenesis and multiple mechanisms contribute to a stable G1 quiescence in these cells.
Cyclin E/Cdk2 (CycE/Cdk2) kinase activity is essential for S phase in flies and must be
down-regulated by the cyclin-dependent kinase inhibitor (CKI) p27Dacapo to initiate G1 arrest.
The E2f1 transcription factor induces the expression of replication factors and must be
inhibited to maintain G1 arrest. This is accomplished by a Drosophila retinoblastoma family
member called Rbf1, whose activity is controlled by phosphorylation. Hypo-phosphorylated
Rbf1 can bind the E2f1 transcription factor and repress target gene expression.
Phosphorylation of Rbf1 by CycE/Cdk2 results in the dissociation of Rbf1-E2f1 repressor
complexes and the expression of replication factors
iii
Here, I show that embryonic Rbf1 activity is regulated by phosphorylation, and that
the conversion of Rbf1 to an active repressor just prior to G1 arrest occurs by the
developmental induction of p27Dacapo, which inhibits the Rbf1 kinase CycE/Cdk2.
Surprisingly, however, the initial termination of E2f1-target gene expression occurs
independently of Rbf1. Rather, my data suggest that the S phase-coupled destruction of E2f1
protein likely contributes to this initial termination of target gene expression.
Since biochemical data in mammals suggest that type 1 protein phosphatases (PP1)
regulate pRb activity, I tested genetically whether PP1 regulates Rbf1 activity in Drosophila.
Interestingly, PP1 is not required for Rbf1-mediated repression during G1 arrest in the
embryonic epidermis or for the regulation of Rbf1 activity during the endocycle in the
embryonic midgut or larval salivary gland. This suggests that another phosphatase family
member may counteract CycE/Cdk2 inhibition of Rbf1 in flies.
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CHAPTER I
INTRODUCTION
One of the primary interests of a developmental biologist is to understand how a fully
differentiated organism can form from a group of actively proliferating cells. While there is
often a great deal of focus placed on analyzing the mechanisms that promote cell
proliferation, it is equally important to describe the mechanisms involved in cell cycle exit.
Therefore, researchers are presented with the following question: how do cells know when to
stop proliferating (i.e. exit the cell cycle) and ultimately begin the process of differentiation?
To address this question, it is imperative to become familiar with the force that drives
proliferation, the cell cycle. The canonical cell cycle consists of four phases: G1, S
(synthesis), G2, and M (mitosis). DNA is replicated during the synthesis phase and this
newly replicated DNA is segregated to daughter cells during mitosis. The gap phases, G1
and G2, are generally described as points in the cycle when the cell is not undergoing
replication or mitosis. There are many factors that regulate this canonical cell cycle, most of
which tend to function at the major transitions including the G1 to S transition and the G2 to
M transition. Some of these factors include transcription factors and Cyclin/Cyclin-
dependent kinase complexes (Cyc/Cdk). Since most cells exit the cell cycle during G1, it is
important to understand how the activities of the transcription factors and Cyc/Cdk
complexes that promote S phase entry are restrained. Generally, transcription factors are
2negatively regulated by transcriptional repressors and Cyc/Cdk complexes are negatively
regulated by cyclin-dependent kinase inhibitors (CKIs).
Mechanisms of G1 arrest in mammalian systems
In mammals, the G1 to S transition is primarily controlled by the activity of the E2
factor (E2F) family of transcription factors. E2F was first identified as the cellular factor that
is required for the activation of the E2 viral promoter (Dyson, 1998). Although there are
currently eight members of this family, only three are considered to be potent activators of
transcription. E2F1, E2F2, and E2F3 are necessary for the expression of DNA replication
factors as well as cell cycle regulators, and this activity is required for cellular proliferation
(Dimova and Dyson, 2005). In the absence of E2F3, proliferation of mouse embryonic
fibroblasts (MEFs) is compromised (Humbert et al., 2000) and the loss of all three
“activator” E2F’s completely blocks proliferation (Wu et al., 2001). E2F is a heterodimer
composed of an E2f subunit and a Dp subunit that together are necessary for binding DNA
(Trimarchi and Lees, 2002). The activity of this heterodimer is controlled primarily through
interaction with members of the retinoblastoma (pRb) tumor suppressor or “pocket protein”
family (DeGregori, 2002; Dimova and Dyson, 2005; Trimarchi and Lees, 2002). This family
is composed of pRb and the closely related proteins, p107 and p130. Although p107 and
p130 are more similar to one another than to pRb, all three family members resemble each
other in the “pocket region,” which is composed of two domains denoted the A and B boxes.
Pocket proteins bind to target proteins, including E2F, through this pocket region (Lipinski
and Jacks, 1999). During quiescence and early G1, hypo-phosphorylated pocket proteins
form a complex with E2Fs that recruit co-repressors and result in the down-regulation of E2F
transcriptional targets. Upon mitogenic stimulation, G1 Cyc/Cdk complexes phosphorylate
3pocket proteins resulting in the dissociation of repressive pocket-protein-E2F complexes and
the transcription of S phase genes (Figure 1.1). The repression of E2F-target genes
contributes to cell cycle arrest during G1 and the role of pRb in maintaining this G1 arrest
has been well-defined. The loss of pRb compromises cell cycle arrest in the lens and neural
tissue as well as in trophoblasts and keratinocytes, most likely because of an inappropriate
increase in E2F activity and a consequent activation of replication factors (Jacks et al., 1992;
MacPherson et al., 2003; Ruiz et al., 2004; Wu et al., 2003)
Figure 1.1: Regulation of E2F transcription factor activity. The E2F transcription factor is a heterodimer
composed of an E2f subunit and a Dp subunit and is necessary for the expression of replication factors such as
the small subunit of ribonucleotide reductase (RnrS). The activity of this transcription factor is negatively
regulated by pocket protein family members such as pRb, the retinoblastoma tumor suppressor protein. When
pRb is hypo-phosphorylated (right), it can bind the E2F transcription factor and repress target gene expression.
Phosphorylation of pRb by CycD/Cdk4 and CycE/Cdk2 complexes (left) results in the dissociation of pRb-E2F
complexes and the transcription of replication factors such as RnrS.
4Along with E2F, the G1 to S transition is promoted by the activity of Cyc/Cdk
complexes including CycD/Cdk4 or 6 and CycE/Cdk2. When cells are stimulated to enter
the cell cycle by mitogenic signals, the expression of D-type cyclins is up-regulated resulting
in the formation of active CycD/Cdk4 and CycD/Cdk6 complexes. These complexes
contribute to cell cycle progression in two ways: first, they are responsible for the
phosphorylation of pRb and second, they contribute to the activation of CycE/Cdk2 by
titration of CKIs (Sherr and Roberts, 1999). This allows for complete phosphorylation of
pRb and dissociation of pRb-E2F complexes as well as direct activation of replication
(Jackson et al., 1995; Ohtsubo et al., 1995; Strausfeld et al., 1996). The activities of
CycD/Cdk4 or 6 and CycE/Cdk2 are primarily restricted by the CKIs p16INK4a and p27Kip1,
respectively (Sherr and Roberts, 1999). While p16INK4a acts as a tumor suppressor, p27Kip1
plays a major role in cell cycle arrest and withdrawal during development. Mice lacking
p27Kip1 are larger than their siblings because of a general overgrowth in a number of tissues
resulting from inappropriate cell proliferation (Fero et al., 1996; Kiyokawa et al., 1996;
Nakayama et al., 1996). Failure to exit the cell cycle in p27Kip1 mutant animals ultimately
disrupts differentiation in the mammalian retina, the organ of Corti, and skeletal muscle
(Chen and Segil, 1999; Chu and Lim, 2000; Levine et al., 2000; Lowenheim et al., 1999;
Zabludoff et al., 1998)
The Drosophila melanogaster embryonic cell cycle program
The Drosophila embryo serves as an excellent system in which to model G1 arrest
during differentiation because the introduction of G1 has been well-characterized (Lee and
Orr-Weaver, 2003) and because Drosophila biologists have created sophisticated genetic and
5cell biological tools with which to study the various functions of cell cycle regulators, which
are remarkably conserved from mammalian systems. The first thirteen cell cycles in the
Drosophila embryo are characterized by the synchronous divisions of zygotic nuclei in a
common cytoplasm. These rapid cell cycles consist solely of replication (S phase) and
mitosis (M phase) without intervening gap phases, and are driven by ubiquitous maternal
factors (Foe and Alberts, 1983). Data suggest that these early cycles are regulated by the
nucleocytoplasmic ratio (N/C), which results in the cessation of these cycles when the ratio
of DNA to cytoplasm reaches a certain threshold (Edgar et al., 1986; Grosshans et al., 2003).
Following the completion of cycle 13, cellularization occurs, marking the start of zygotic
transcription. During cell cycle 14, the degradation of maternal string mRNA and protein
results in the introduction of the first gap phase during embryogenesis, G2 (Edgar and Datar,
1996). String (stg) is the Drosophila homolog of the Cdc25 phosphatase, which functions to
remove the inhibitory phosphates from Cdk1, thus activating Cyclin A/Cdk1 and Cyclin
B/Cdk1 complexes and promoting entry into mitosis (Edgar and O'Farrell, 1989; Sigrist et
al., 1995). The three postblastoderm divisions (cycles 14-16) are characterized by a cell
cycle consisting of S-G2-M and occur in a spatially and temporally regulated manner,
resulting in the mitotic domains of the embryo (Foe, 1989). Regulated transcription of stg at
the G2-M transition controls progress through these postblastoderm cell cycles (Edgar and
O'Farrell, 1990; Edgar et al., 1994). The first G1 is not introduced until cell cycle 17 (Figure
1.2). Following mitosis of cell cycle 16, most of the cells in the embryo will arrest in G1
(Smith and Orr-Weaver, 1991). Some cells, such as those of the epidermis, will remain
arrested until embryogenesis is completed. Other cells, like those of the nervous system and
those that will give rise to larval tissues (e.g. midgut, hindgut, anal pad) will continue to
6cycle. The cells of the nervous system utilize a cell cycle similar to that used in the
postblastoderm divisions, while those that will give rise to larval tissues enter the endocycle,
a non-canonical cycle consisting of gap phase (G) and S phase (without mitosis) which
results in the polyploidization of tissues (Lee and Orr-Weaver, 2003; Smith and Orr-Weaver,
1991).
Figure 1.2: Schematic diagram of the embryonic cell cycle program. In the Drosophila embryo, the first
thirteen cell cycles consist solely of replication (S) and mitosis (M) without any intervening gap phases (G).
During cell cycle 14, degradation of maternal stg mRNA and protein results in the introduction of G2. The so-
called post-blastoderm divisions (cycles 14-16) consist of S-G2-M cell cycles where the G2-M transition is
controlled by the regulated transcription of stg. Following mitosis of cycle 16, most of the cells in the embryo
arrest in G1 of cycle 17. Some cells (i.e. epidermis) remain arrested in G1 for the remainder of embryogenesis
while others (i.e. midgut) re-enter the cell and utilize the non-canonical endocycle (G1-S) which is controlled by
the oscillations of Cyclin E protein.
Mechanisms of G1 arrest in the Drosophila embryo
The factors that promote the G1 to S transition in mammalian systems, such as
CycE/Cdk2 and E2F, are well-conserved in Drosophila. While the activities of these factors
7are relatively ubiquitous in the early embryo, they become regulated prior to the introduction
of the first G1 phase at cell cycle 17. CycE/Cdk2 is required for S phase entry in Drosophila
as this complex plays a critical role in the association of minichromosome maintenance
(MCM) proteins (members of the pre-replication complex) with chromatin (Knoblich et al.,
1994; Su and O'Farrell, 1997). Since there is a large maternal contribution of Cyclin E
protein (Richardson et al., 1993), the first sixteen cell cycles are not affected in zygotic cycE-
mutant embryos; however, S phase is abrogated in cells that are both mitotically dividing and
endocycling following cell cycle 16 (Knoblich et al., 1994). The inhibition of CycE/Cdk2
activity is required to prevent cells from entering S phase in cell cycle 17 and to promote G1
arrest. This is accomplished in part by zygotic transcription of the CKI dacapo (Dap), the
single Drosophila p27Kip1 homolog (de Nooij et al., 1996; Lane et al., 1996). p27Dap is
transcriptionally up-regulated in the embryonic epidermis during cell cycle 16, just prior to
the introduction of G1 arrest, and it specifically inhibits the activity of CycE/Cdk2 by
physically associating with both members of the complex (de Nooij et al., 1996; Lane et al.,
1996). As a result, epidermal cells in p27Dap-mutant embryos fail to arrest in G1 of cycle 17;
rather they inappropriately enter S phase of cycle 17 and complete one extra round of
division until finally arresting in G1 of cell cycle 18 (de Nooij et al., 1996; Lane et al., 1996).
Interestingly, p27Dap expression is developmentally regulated and controlled by a complex
regulatory region (de Nooij et al., 2000; Liu et al., 2002; Meyer et al., 2002b).
Although the inhibition of CycE/Cdk2 by p27Dap is required for G1 arrest, it is not
sufficient to maintain this arrest for the remainder of embryogenesis. The maintenance of G1
arrest in the embryonic epidermis requires the inhibition of the E2F transcription factor in
this tissue. In Drosophila, there are two E2f genes (E2f1 and E2f2) and one Dp gene
8(DeGregori, 2002). E2f1 is necessary for the expression of replication factor genes including
Cyclin E, RnrS (ribonucleotide reducatse), and PCNA (proliferating cell nuclear antigen)
(Duronio et al., 1998; Duronio et al., 1995; Royzman et al., 1997; Thacker et al., 2003)
whereas E2f2 promotes the repression of genes involved in developmental processes other
than cell cycle progression (Dimova et al., 2003; Korenjak et al., 2004; Lewis et al., 2004).
In both zygotic E2f1 and Dp-mutants, target gene expression is lost in the central nervous
system (CNS) and the endodomains in germ band-retracted embryos, although expression is
not compromised in post-blastoderm embryos, presumably because of the maternal
contribution of each gene (Duronio et al., 1998; Duronio et al., 1995; Royzman et al., 1997).
In the embryonic epidermis of germ band-retracted embryos, E2f1-target gene expression is
restricted by Rbf1, the Drosophila pRb homolog (Du et al., 1996). Rbf1-mutant embryos
(maternal and zygotic) develop normally through cell cycle 17, and the epidermal cells are
capable of entering G1 arrest because p27Dap inhibits the activity of CycE/Cdk2. However,
this G1 arrest is not maintained and some cells re-enter the cell cycle because of
inappropriate expression of E2f1-target genes including Cyclin E (Du and Dyson, 1999).
Interestingly, these cells do not complete a mitotic cell cycle as some are lost through
apoptosis (Du and Dyson, 1999).
9Figure 1.3: Schematic of interactions among G1-S regulators in Drosophila. The E2f1 transcription factor
is necessary for the expression of replication factors such as Cyclin E and its activity is negatively regulated by
one of the retinoblastoma family members in flies, Rbf1. Phosphorylation of Rbf1 by CycE/Cdk2 complexes
results in the activation of E2f1. The activity of CycE/Cdk2 complexes is antagonized by the CKI, p27Dap.
Although Rbf1 is required to restrict E2f1-target gene expression in the epidermis of
germ band-retracted embryos, the mechanisms that contribute to the initial termination of
expression remain unclear. Conceptually, there are two possible ways that this termination
could occur: either through the destruction of E2f1 protein or through the activation of Rbf1.
There is a growing body of evidence suggesting that E2f1 protein levels are regulated by the
ubiquitin-proteosome pathway (Harper and Elledge, 1999). In this pathway, E3 ubiquitin
ligases mediate the transfer of ubiquitin to various substrates resulting in their destruction by
the 26S proteosome. In mammalian systems, the SCF (Skp1-Cullin 1-F-box) class of E3
ubiquitin ligases, and more specifically SCFSkp2, has been implicated in E2f1 destruction
(Marti et al., 1999). This mechanism of E2f1 protein degradation appears to be conserved in
Drosophila. In larval eye and wing imaginal discs, E2f1 is destroyed at the G1 to S
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transition (Asano et al., 1996; Heriche et al., 2003; Reis and Edgar, 2004), and this
destruction involves the ubiquitin-proteosome pathway (Heriche et al., 2003). Therefore, it is
reasonable to hypothesize that the initial termination of E2f1-target gene expression prior to
the introduction of G1 arrest in the embryonic epidermis could result from the regulated
destruction of E2f1 protein.
It is also reasonable to hypothesize that the activation of Rbf1 contributes to the
termination of target gene expression in the cells of the epidermis. Rbf1 is found at both the
mRNA and protein level throughout early embryogenesis (Keller et al., 2005; Stevaux et al.,
2002) yet the ubiquitous expression of E2f1-regulated replication factors is not disrupted in
the first sixteen cell cycles. This suggests that Rbf1 is regulated post-translationally in the
Drosophila embryo. Like mammalian pocket protein family members, Rbf1 activity is
mediated by phosphorylation. Hypo-phosphorylated Rbf1 can bind E2f1/Dp complexes and
repress their transcriptional activity (Du et al., 1996). Upon phosphorylation by S phase-
promoting Cyc/Cdk complexes, such as CycD/Cdk4 and CycE/Cdk2, the physical
association between Rbf1 and E2f1/Dp is disrupted therefore relieving the repression on
E2f1-target gene expression (Xin et al., 2002). Assuming that Rbf1 is kept inactive by
phosphorylation in the early embryo, altering the phosphorylation status of Rbf1 should be
sufficient to activate this protein as a repressor of E2f1. This could be accomplished by
inhibiting the activity of the Cyc/Cdk complexes that phosphorylate Rbf1. Since E2f1-target
gene expression is regulated properly in the epidermis of both CycD- and Cdk4-mutant
embryos, it is unlikely that modifying the activity of CycD/Cdk4 complexes is part of the
mechanism (Emmerich et al., 2004; Meyer et al., 2002a). Therefore, the inhibition of
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CycE/Cdk2 activity by p27Dap may contribute to the activation of Rbf1 as a repressor of
E2f1.
It is equally possible that a change in the phosphorylation status of Rbf1 results from
the activation of a phosphatase. Data from mammalian systems suggest that type 1 protein
phosphatases (PP1) are responsible for the de-phosphorylation of pRb during mitosis and this
activates pRb for the next G1 phase (Ludlow et al., 1993; Ludlow et al., 1990; Tamrakar et
al., 2000). PP1 is an extremely well-conserved protein that is involved in a number of
processes including mitosis, muscle contraction, RNA processing, and glycogen metabolism
(Cohen, 2002). It exists as a holoenzyme composed of a catalytic subunit and a regulatory
subunit, which functions to target PP1 to its various substrates (Ceulemans and Bollen,
2004). There are multiple PP1 isoforms in mammals and each can de-phosphorylate pRb,
although PP1 appears to be the most efficient (Nelson et al., 1997; Rubin et al., 2001). In
Drosophila there are two subtypes of PP1 catalytic subunits: PP1, which is homologous to
mammalian PP1 and PP1, and PP1, which is homologous to PP1/ (Dombradi et al.,
1993). While there are three genes that encode PP1-isozymes (PP113C, PP187B, and
PP196A), there is only one gene that encodes for PP1 (PP19C or flw). PP19C (flw) has
a specific role in the maintenance of indirect flight muscle attachment and cell adhesion in
non-muscle tissue which is mediated through the regulation of non-muscle myosin.
(Raghavan et al., 2000; Vereshchagina et al., 2004). Data suggests that PP196A may also
participate in this regulation of non-muscle myosin (Kirchner et al., 2007). Until recently,
only PP187B has been implicated in cell cycle control. This catalytic subunit is important
for progression through mitosis since null mutations result in over-condensed chromosomes,
hyperploidy, and spindle defects in larval brain squashes (Axton et al., 1990). However, a
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RNAi screen in Drosophila S2 cells has also linked PP19C (flw) to mitotic progression
(Chen et al., 2007). Although PP1 has an established role in cell cycle regulation, its putative
substrates have not been defined. Therefore, it would be interesting to determine the
contribution of PP1 to the phosphorylation status of Rbf1 and possibly defining its role in the
establishment of G1 during Drosophila embryogenesis.
Although Rbf1 has a well-established role in regulating E2f1-target gene expression
in the embryonic epidermis, it is also required in the embryonic midgut for the proper
regulation of target gene expression and endocycle progression (Du and Dyson, 1999).
Following G1 arrest, cells of the midgut re-enter S phase and begin endocycles, where gap
phase and S phase alternate (Lee and Orr-Weaver, 2003). Separate regions of the embryonic
midgut differentially enter and exit S phase, generating a characteristic pattern of coincident
BrdU incorporation (S phase marker) and E2f1-target gene expression (e.g. RnrS). For
example, during stage 14 (cell cycle 18) the central midgut cells are in S phase and therefore
incorporate BrdU and express RnrS, while the anterior and posterior midgut cells are in a gap
phase and do not incorporate BrdU nor express RnrS . In stage 14 rbf1-mutant (maternal and
zygotic) embryos, BrdU incorporation as well as E2f1-target gene expression is seen
throughout the midgut rather than just in the central midgut as seen in wild type embryos (Du
and Dyson, 1999). While it is clear that Rbf1 participates in the regulation of the midgut
endocycle, the mechanism by which Rbf1 activity is controlled in this alternative cell cycle
has not been established.
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Dissertation Goals
In the Drosophila cell cycle field, the mechanism involved in the initial termination
of E2f1-target gene expression in the embryonic epidermis and the factors that regulate Rbf1
activity in these epidermal cells as well as endocycling tissues have remained elusive. In this
thesis, I will describe the work that I performed to further our understanding of both issues.
Chapter 2 represents a collaborative effort between myself and another graduate student,
Shusaku Shibutani. We characterized Rbf1 regulation in the embryonic epidermis and
determined that the activity of this protein is regulated by phosphorylation. In the early
embryo, Rbf1 is maintained in a hyper-phosphorylated and thus inactive form. However,
Rbf1 becomes active as a repressor of E2f1-target gene expression by conversion to a hypo-
phosphorylated form which is mediated by the CKI, p27Dap. Surprisingly, we show that the
regulated proteolysis of E2f1 during S phase, and not Rbf1, contributes to the initial
termination of E2f1-target gene expression in the embryonic epidermis.
Chapter 3 describes the work that I performed to further elucidate the regulation of
Rbf1 activity in both the G1-arrested epidermis and endocycling tissues. I found that Rbf1
activity is not regulated by type 1 protein phosphatases (PP1) in the cells of the epidermis.
This was not an expected result because the role of PP1 in pRb regulation in mammalian
systems has been well-established. I further characterized the regulation of Rbf1 activity in
the endocycling midgut. Although Rbf1 is also regulated by phosphorylation in this tissue,
PP1 does not appear to control Rbf1 activity. Rather, we hypothesize that the inhibition of
CycE/Cdk2 activity by p27Dap regulates the phosphorylation status of Rbf1 and this is
important for endocycle control in the midgut. I also found that PP1 does not regulate Rbf1
14
activity in the larval salivary gland but may have a unique role, independent of Rbf1, in
regulating the periodic accumulation of CycE protein in ovarian nurse cell endocycles.
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CHAPTER II
RBF1-INDEPENDENT TERMINATION OF E2F1-TARGET GENE EXPRESSION
DURING EARLY DROSOPHILA EMBRYOGENESIS
Preface
This work was previously published and represents a co-first author effort between
myself and my collaborator, Shusaku Shibutani, a fellow graduate student in the lab. I was
responsible for analyzing the physical interaction between Rbf1 and E2f1 and the effects of
UAS Rbf1-280 over-expression during early embryogenesis. I also measured RnrS expression
and E2f1 protein levels in fzr and Rbf1 mutants, Dap protein levels in stg mutants, and
analyzed E2f1 protein dynamics during mitosis. Shusaku measured RnrS expression in dap-
mutant embryos and embryos where UAS Rbf1-280 was over-expressed. He analyzed E2f1
protein dynamics throughout embryogenesis, paying particular attention to the levels of E2f1
during S phase. He also monitored E2f1 protein levels in a variety of mutant situations and
measured Dap protein levels in dap;stg double mutants. Both Shusaku and I contributed to the
writing of the manuscript while Robert Duronio conceived the project and finalized the
manuscript.
Shibutani, S., Swanhart, L.M., and Duronio, R.J. (2007). Rbf1-independent
termination of E2f1-target gene expression during early Drosophila
embryogenesis. Development 134, 467-78.
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Abstract
The initiation and maintenance of G1 cell cycle arrest is a key feature of animal
development. In the Drosophila ectoderm, G1 arrest first appears during the 17th embryonic
cell cycle. The initiation of G117 arrest requires the developmentally-induced expression of
Dacapo, a p27-like Cyclin E/Cdk2 inhibitor. The maintenance of G117 arrest requires Rbf1-
dependent repression of E2f1-regulated replication factor genes, which are expressed
continuously during cycles 1-16 when S phase immediately follows mitosis. The
mechanisms that trigger Rbf1 repressor function and mediate G117 maintenance are
unknown. Here we show that the initial down regulation of expression of the E2f1 target
gene RnrS, which occurs during cycles 15 and 16 prior to entry into G117, does not require
Rbf1 or p27Dap. This suggests a mechanism for Rbf1-independent control of E2f1 during
early development. We show that E2f1 protein is destroyed in a cell cycle dependent manner
during S phase of cycles 15 and 16. E2f1 is destroyed during early S phase, and requires
ongoing DNA replication. E2f1 protein re-accumulates in G117 arrested epidermal cells, and
in these cells the induction of p27Dap activates Rbf1 to repress E2f1 target genes to maintain a
stable G1 arrest.
Introduction
Proper control of cell cycle exit is an essential aspect of the development of all multi-
cellular organisms. Cell cycle exit frequently occurs during G1 phase, and a stable G1 arrest
is usually necessary for cell differentiation (Myster and Duronio, 2000). Multiple
mechanisms contribute to stable G1 quiescence, and these mechanisms can be broadly
defined as those that initiate the onset of G1 arrest and those that maintain G1 arrest.
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Disruption of either or both types of regulation can abrogate differentiation, block
morphogenesis, and contribute to the onset of cancer.
The initiation of G1 arrest involves the inhibition of G1 Cyclin/Cyclin dependent
kinase (Cdk) complexes that promote entry into S phase. These kinases include Cyclin
D/Cdk4 (CycD/Cdk4) and Cyclin E/Cdk2 (CycE/Cdk2), which are negatively regulated by
the cyclin dependent kinase inhibitors (CKIs) p16INK4a and p27Kip1, respectively (Sherr and
Roberts, 1999). Whereas p16INK4a acts primarily as a tumor suppressor, the induction of p27
expression is required for proper cell cycle withdrawal and subsequent differentiation in a
number of developing mammalian tissues, including the retina, the organ of Corti, and
skeletal muscle (Chen and Segil, 1999; Chu and Lim, 2000; Levine et al., 2000; Lowenheim
et al., 1999; Zabludoff et al., 1998).
The maintenance of G1 arrest occurs through a distinct mechanism involving the
repression of genes necessary for S phase, which are regulated by the E2F family of
transcription factors. E2F activity is controlled mainly through interaction with members of
the retinoblastoma (pRb) tumor suppressor or “pocket protein” family (DeGregori, 2002;
Dimova and Dyson, 2005; Trimarchi and Lees, 2002). During quiescence and early G1,
hypo-phosphorylated pocket proteins form a complex with E2Fs that recruit co-repressors
and results in the down-regulation of E2F targets. In response to growth signals, G1
Cyclin/Cdk complexes phosphorylate pocket proteins resulting in the dissociation of the
repressive pocket protein/E2F complex and the induction of transcription of S phase genes.
In lens cells, trophoblasts, keratinocytes, and neural tissue the maintenance of cell cycle
arrest is compromised by the loss of pRb, presumably due to an inappropriate increase in E2F
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activity and the consequent activation of replication genes (Jacks et al., 1992; MacPherson et
al., 2003; Ruiz et al., 2004; Wu et al., 2003).
E2F activity can also be regulated independently of pocket proteins. “E2F” is a
heterodimer composed of an E2f subunit and a Dp subunit that together are necessary for
binding DNA (Trimarchi and Lees, 2002). During S phase, CycA/Cdk2 phosphorylates E2f-
bound Dp resulting in dissociation of the E2f-Dp heterodimer from DNA (Dynlacht et al.,
1994; Dynlacht et al., 1997; Krek et al., 1994; Krek et al., 1995). Other reports indicate that
in mammalian cells E2F proteins are destroyed in S/G2 via the ubiquitin-proteasome
pathway (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996;
Marti et al., 1999). Similarly, E2f1 is destroyed at the G1/S transition in Drosophila
imaginal disc cells (Asano et al., 1996; Heriche et al., 2003; Reis and Edgar, 2004), and this
destruction involves the ubiquitin-proteasome pathway (Heriche et al., 2003). Whether these
modes of E2F regulation contribute substantially to gene expression and cell cycle control
during development is not known.
In a variety of animal species, the cell cycles of early embryonic development display
several common features. In general, these cell cycles are very rapid and occur with the
ubiquitous activity of key regulators such as E2F and CycE/Cdk2. In some instances (e.g.
Drosophila and Xenopus) the earliest cell cycles lack measurable gap phases altogether. As
development proceeds, different lineages first acquire additional cell cycle controls that result
in the appearance of gap phases, and then undergo cell cycle exit and differentiation. The
mechanisms contributing to specific changes in cell cycle regulation in particular tissue types
during development remain incompletely understood.
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Drosophila embryos provide an excellent experimental system to address this issue
because they execute a stereotyped, developmentally-controlled cell cycle program that is
well-characterized (Lee and Orr-Weaver, 2003) (Figure. 2.1I). The first 13 cycles are rapid
S-M cycles driven by ubiquitous maternal factors (Foe and Alberts, 1983). The first gap
phase, G2, appears at the blastoderm stage during cell cycle 14 because of degradation of
maternal string (stg) mRNA and protein (Edgar and Datar, 1996). stg encodes a Cdc25-type
phosphatase that removes the inhibitory phosphates from Cdk1 to allow entry into mitosis
(Edgar and O'Farrell, 1989; Sigrist and Lehner, 1997). After gastrulation begins, a pulse of
zygotic transcription of stg in late G2 triggers the entry into mitosis during cycles 14, 15 and
16 (Edgar et al., 1994; Edgar and O'Farrell, 1990). In these so-called post-blastoderm
division cycles there is no G1 phase, and S phase begins immediately after mitosis. G1 phase
first appears during cell cycle 17, after which some cells (e.g. in the epidermis) remain
arrested in G117 while others (e.g. in the midgut) re-enter S phase from G117 and begin
endoreduplication cycles.
The regulation of stg establishes a paradigm for developmental control of the
Drosophila embryonic cell cycle. The transition from ubiquitous, maternally-provided stg to
regulated, zygotic expression of stg accounts for both the introduction of the first G2 phase
and subsequent G2-M cell cycle regulation. This paradigm also applies to the introduction of
G1-S regulation in cell cycle 17. Because Cyclin E is required for S phase in Drosophila
(Knoblich et al., 1994), the change in activity of CycE/Cdk2 from ubiquitous (cycles 1-16) to
cell cycle-regulated accounts for both the introduction of G1 phase in cycle 17 and
subsequent regulation of the G1-S transition (Duronio and O'Farrell, 1995; Richardson et al.,
1993; Sauer et al., 1995). This transition is achieved in part by zygotic transcription of
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dacapo (dap), which encodes the single Drosophila p27-like CKI (de Nooij et al., 1996;
Lane et al., 1996). dap transcription is controlled by a complex cis-acting regulatory region
that responds to developmental inputs that induce Dap production during cycle 16 (Liu et al.,
2002; Meyer et al., 2002b). This results in the inhibition of CycE/Cdk2 and the appearance
of G1 in cycle 17. Consequently, dap mutant epidermal cells do not enter G117, but instead
enter S17 immediately after the completion of M16 and undergo an ectopic cell division cycle
(de Nooij et al., 1996; Lane et al., 1996).
The maintenance of a stable G117 arrest in the embryonic epidermis requires the
function of Rbf1, a Drosophila pRb homolog (Du et al., 1996a). Rbf1 negatively regulates
the activity of E2f1. In Drosophila, E2f1 is necessary for the expression of replication factor
genes including Cyclin E, although these genes are also regulated by additional factors such
as DREF (Duronio et al., 1998; Duronio et al., 1995; Hirose et al., 1993; Royzman et al.,
1997; Sawado et al., 1998; Yamaguchi et al., 1996). Rbf1 mutant embryos develop normally
through cycle 17, and the epidermal cells are able to initiate G117 due to the activity of Dap.
However, some Rbf1 mutant epidermal cells fail to maintain G1 arrest and ultimately re-enter
the cell cycle because of inappropriate expression of E2f1 target genes including Cyclin E
(Du and Dyson, 1999). The developmental inputs and mechanisms that result in Rbf1
repressor function and the down-regulation of replication genes are unknown. Here we show
that, surprisingly, the initial down regulation of the E2f1 target gene RnrS prior to G117 does
not require Rbf1 or Dap. Instead, loss of RnrS expression occurs coincident with the onset of
S phase-coupled destruction of E2f1 protein, which may provide a mechanism for pRb-
independent regulation of E2F activity.
28
Materials and Methods
Drosophila strains
w
1118
, prd-Gal4,  tubulin FLP, w ovoD FRT 14A-B/C(1)DX, y f/Y; hsFLP, and
CycEAR95/CyO were obtained from the Bloomington Stock Center. UAS dap, dap4454/CyO,
Df(1)biD3/FM7, dupa1/CyO, dupa3/CyO, arm-Gal4 VP16/TM3 and E2f17172/TM3 have been
described previously (de Nooij et al., 1996; Duronio et al., 1995; Lane et al., 1996; McEwen
et al., 2000; Sigrist and Lehner, 1997; Spradling et al., 1995; Whittaker et al., 2000). y w;
stg7B/TM3 e as well as UAS Rbf-280/TM3, UAS Rbf1, and Rbf114 FRT14A-B/FM7 were
kindly provided by Patrick O’Farrell and Wei Du, respectively (Du and Dyson, 1999; Edgar
and O'Farrell, 1989; Xin et al., 2002). dap4454/CyO wg-lacZ, Df(1)biD3/FM7Actin-GFP,
dupa1/CyO wg-lacZ, dupa3/CyO wg-lacZ, CycEAR95/CyO wg-lacZ, and Rbf114 FRT 14A-
B/FM7 Actin-GFP were constructed for this study. Rbf114 germ line clones were generated as
described (Du and Dyson, 1999). stg7B dap4454 double mutant embryos were unambiguously
identified using Dap antibody staining and the altered morphology caused by the stg G214
arrest phenotype.
RNA in situ hybridization and BrdU labeling
Embryos were dechorionated, fixed in a 1:1 mixture of 4% formaldehyde in
PBS/heptane for 25 minutes, and devitellinized with methanol. For BrdU labeling,
dechorionated embryos were permeabilized with octane, pulse-labeled with 1mg/ml BrdU for
either 5 minutes or 15 minutes in Schneider’s Drosophila medium prior to fixation. Embryos
were stored in methanol at -20˚C.
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In situ hybridization with digoxigenin-labeled antisense RNA probes was performed
as described (Kearney et al., 2004). Fluorescent detection of hybrids (FISH) was achieved
with the TSA Fluorescence System (Perkin Elmer) using a 30 minutes to 1 hour incubation in
TSA-Cy3 or TSA-Fluorescein. For all triple fluorescent staining (i.e. FISH anti-protein, anti-
BrdU) except E2f1 or Dap plus FISH, embryos were first processed for FISH, then for
immuno-detection of proteins, and finally for BrdU detection by acid denaturation of
chromosomes (Schubiger and Palka, 1987). For E2f1 or Dap detection plus FISH, the TSA
Fluorescence System was first used for immuno-detection of E2f1 or Dap, and then the
embryos were fixed for 30 minutes in 4% formaldehyde to quench the peroxidase prior to
FISH and BrdU detection.
Immunostaining
Embryos were re-hydrated with PBS/0.1% Tween20 (PBS-T) and incubated with
primary antibodies overnight at 4˚C. Primary antibodies were: mouse anti-BrdU monoclonal
antibody (1:100, Becton Dickinson), rabbit anti-E2f1 (1:500 or 1:1000, gift of Maki Asano)
(Asano et al., 1996), rabbit anti-phospho-tyrosine (1:100, Upstate), rat anti-phospho-tyrosine
(1:50 or 1:100, R and D Systems), rabbit anti- galactosidase (1:200, Chemicon), mouse anti-
phospho-Ser10-histone H3 (1:2000, Upstate), rabbit anti-GFP (1:2000, Abcam) and rabbit
anti-Dap (Lane et al., 1996) (1:600). Secondary antibodies were: goat anti-mouse Oregon
Green (1:1000, Molecular Probes), goat anti-mouse-Cy5 (1:500, Jackson), goat anti-mouse-
Cy3 (1:500, Jackson), goat anti-rabbit-Cy2 (1:500, Jackson), goat anti-rabbit rhodamine
(1:1000, Molecular Probes), donkey anti-rat-Cy5 (1:500, Jackson), and goat anti-rabbit-Cy5
(1:500, Abcam). For detection of E2f1 and Dap, the TSA Fluorescence System (Perkin
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Elmer) was used with a biotin-conjugated anti-rabbit secondary antibody (1:1000,
Chemicon). Stained embryos were mounted with Fluoromount-G (Southern Biotech) and
visualized with either a Nikon Eclipse E800 microscope or a Zeiss LSM 510 scanning
confocal microscope.
Co-immunoprecipitations and western blotting
Immunoprecipitations were performed with extracts from 0-4 hour and 5-8 hour w1118
embryos as described (Peifer et al., 1993), and analyzed by SDS-PAGE (7.5% pre-cast gel,
Biorad) and western blotting with mouse anti-Rbf1 (DX-3, 1:4; (Du et al., 1996a)), rabbit
anti-E2f1 (see above), and mouse anti-Dp (YUN1-3 1:4; (Du et al., 1996b)). Secondary
antibodies were ECL™-Sheep anti-mouse HRP (1:5000) and ECL™-Donkey anti-rabbit
HRP (1:5000) from Amersham Biosciences.
Results
Phosphorylation controls the activity of Rbf1 in the early embryo
The transcripts of E2f1-regulated replication factor genes are present during the first
16 embryonic cycles even though Rbf1 mRNA and protein are present continuously
throughout all of early embryogenesis (Keller et al., 2005; Stevaux et al., 2002). This
suggests that embryonic Rbf1 activity is regulated post-translationally. We therefore
hypothesized that Rbf1 is hyper-phosphorylated and thus inactivated until cycle 16 by
constitutive G1 Cyclin/Cdk activity, resulting in ubiquitous expression of E2f1 target genes
(Figure. 2.1I). To test this, we utilized a mutant version of Rbf1 (Rbf-280) containing
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mutations in four Cdk consensus sites that cannot be inhibited by the activity of G1
Cyclin/Cdk
Figure 2.1: Rbf1 activity is controlled by phosphorylation in the early embryo. (A-G) in situ hybridization
of stage 10 embryos with an RnrS probe. (A) Sibling control embryo from a collection expressing UAS-Rbf1
with prd-Gal4. (B) UAS Rbf1/prd-Gal4. Arrow marks paired-expressing segment. (C) UAS Rbf-280/prd-
Gal4. Arrow denotes the precocious termination of RnrS expression in a paired expressing segment. (D) UAS
Rbf-280/prd-Gal4 embryo pulse labeled for 15 minutes with BrdU (green). RnrS expression detected by FISH
(red). Arrow and arrowhead indicate cells in cycle 15 and 16, respectively. (E) Sibling embryo from a
collection expressing UAS Rbf-280 with arm-Gal4 VP16. (F) UAS Rbf1/arm-Gal4 VP16. (G) UAS Rbf-
280/arm-Gal4 VP16. (H) Rbf1 was immuno-precipitated from 0-4 and 5-8 hour old w1118 embryo extracts, and
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the IPs were probed for the presence of E2f1 and Dp by western blotting. (I) Schematic diagrams of the
embryonic cell cycle program and the regulation of E2f1 activity. Scale bar is 200 µm.
complexes (e.g. CycE/Cdk2) (Xin et al., 2002). UAS Rbf-280 was expressed with two strong
drivers that are active during cycles 14-16, prd-Gal4 and arm-Gal4-VP16. E2f1 activity was
monitored by in situ hybridization with a probe derived from the small subunit of
ribonucleotide reductase (RnrS), a well-established E2f1 target gene (Duronio et al., 1995).
UAS Rbf-280 expression with prd-Gal4 resulted in the precocious termination of RnrS
expression in alternating segments (Figure. 2.1A, C). Utilizing fluorescent detection of RnrS
transcripts and BrdU labeling, we confirmed that the precocious termination occurs during
cycle 15 (Figure. 2.1D). A similar but more widespread result was observed using the
ubiquitous arm-Gal4-VP16 driver (Figure. 2.1E, G). Little change in RnrS expression was
observed after expressing wild type Rbf1 (Figure. 2.1B, F), indicating that the precocious
termination of RnrS expression is specific to UAS Rbf-280. These results suggest that Rbf-
280 can bypass the normal mechanism of Rbf1 control in the early embryo, and are
consistent with the idea that Rbf1 is hyper-phosphorylated and thus inactivated by
constitutive Cyclin/Cdk activity in the early embryo to permit expression of replication factor
genes like RnrS.
Rbf1 phosphorylation prevents Rbf1 from binding to E2f1 (Du et al., 1996a; Xin et
al., 2002). Therefore, our interpretation of the Rbf-280 results predicts that Rbf1/E2f1
complexes will not be present during early embryogenesis, and that these complexes will be
detected only after the introduction of G1 control at ~7 hours of development. Consistent
with this hypothesis, E2f1 and Rbf1 co-precipitate from 5-8 hour (cycles 16-17) but not 0-4
hour (prior to cycle 16) embryo extracts (Figure. 2.1H). Dp co-precipitates with Rbf1 in
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both cases (Figure. 2.1H). The Rbf1/Dp interaction in 0-4 hour old embryos likely represents
the recently described Myb-MuvB/dREAM complex that contains E2f2/Dp/Rbf and which
acts to repress many genes involved in developmental processes other than cell cycle
progression (Korenjak et al., 2004; Lewis et al., 2004). We have been unable to detect
hyper-phosphorylated Rbf1 by reduced mobility on SDS-PAGE gels, as is commonly
performed with mammalian pRb. Nevertheless, our results suggest that in early
embryogenesis (cycles 1-16) Rbf1 is present in a hyper-phosphorylated, inactive form that is
not bound to E2f1.
The initial termination of E2f1-target gene expression does not require CycE/Cdk2
inhibition
In wild type embryonic epidermis, the expression of E2f1 targets is terminated prior
to G117, and Rbf1 is required to maintain repression of E2f1 targets during G117 (Du and
Dyson, 1999; Duronio and O'Farrell, 1994; Richardson et al., 1993). Since our data imply
that Rbf1 is hyper-phosphorylated in the early embryo, we hypothesized that prior to the
introduction of G117 Rbf1 is converted to a hypo-phosphorylated form that binds E2f1 and
terminates E2f1 target gene expression. A possible mechanism for the conversion of Rbf1 to
a hypo-phosphorylated form is the inhibition of G1 Cyclin/Cdk complexes, specifically
CycD/Cdk4 and CycE/Cdk2 which in vertebrates are known to phosphorylate pRb (Dyson,
1998). Since the regulation of RnrS expression in the epidermis of both CycD and Cdk4
mutant embryos is normal, the modulation of CycD/Cdk4 activity may not be part of the
mechanism (Emmerich et al., 2004; Meyer et al., 2002a). In contrast, CycE/Cdk2, which can
phosphorylate and inhibit Rbf1 (Du et al., 1996a), is inhibited just prior to the introduction of
34
G117 by the developmentally-regulated induction of dap transcription during cycle 16 (de
Nooij et al., 1996; Lane et al., 1996) (Figure. 2.1I). If the inhibition of CycE/Cdk2 activity
by Dap is necessary for the accumulation of hypo-phosphorylated Rbf1 and the consequent
suppression of E2f1 targets, then in dap mutants RnrS expression would not be terminated
properly. However, RnrS expression is down-regulated in the epidermis of dap mutants prior
to the completion of S16 just as it is in wild type embryos (Figure. 2.2A, B). Moreover, the
termination of RnrS expression occurs even though the epidermal cells of dap mutant
embryos enter an ectopic S17 (Figure. 2.2C, D).
A similar result is seen in the epidermis of fizzy-related (fzr) mutant embryos. fzr
encodes Drosophila Hct1/Cdh1, which during G1 phase targets mitotic cyclins for
ubiquitination by the APC/C and subsequent destruction (Jacobs et al., 2002; Sigrist and
Lehner, 1997). Similar to dap mutants, epidermal cells in fzr mutants fail to exit the cell
cycle and inappropriately enter an ectopic S17 that is likely driven by CycE/Cdk2 (Sigrist and
Lehner, 1997). In spite of this, RnrS expression is properly down-regulated in fzr mutants
(Figure. 2.2E). Thus, while unrestricted CycE/Cdk2 activity can prevent the initiation of
G117 in epidermal cells, E2f1 target gene expression is still terminated at the appropriate
time. These data suggest that either the inhibition of CycE/Cdk2 does not result in the
accumulation of hypo-phosphorylated Rbf1, or that a different mechanism is involved in the
initial termination of E2f1 target gene expression.
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Figure 2.2: E2f1 target gene expression is terminated in mutants containing ectopic CycE/Cdk2.
Embryos were pulse-labeled with BrdU for 5 minutes (A-D) or 15 minutes (E) and were stained for BrdU
incorporation (green) and phospho-tyrosine to highlight cell boundaries (cyan). RnrS expression was detected
by FISH (red). (A) Stage 10 w1118 control embryo. The bar denotes S16 in the dorsal epidermis and the bracket
marks cycle 15 in the ventral epidermis. (B) Stage 10 dap4454/dap4454 embryo. Note that P-Tyr is absent
because anti--Gal was used to distinguish CyO P[wg-lacZ]-containing embryos from the dap mutants. (C)
Control embryo that is a sibling of the embryo in panel D. The arrow denotes cells of the anterior spiracle
primordium that normally enter S17. (D) Stage 11 dap4454/dap4454 embryo. (E) Df(1)biD3/Df(1)biD3 fzr mutant
embryo. Scale bars are 50µm.
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Cell cycle-regulated destruction of E2f1 protein in the embryonic epidermis
One possible mechanism for the inhibition of E2f1 activity is the destruction of E2f1
protein. In both the eye and wing imaginal discs E2f1 protein is destroyed at the G1-S
transition and re-accumulates during G2 and M phase (Asano et al., 1996; Heriche et al.,
2003; Reis and Edgar, 2004). We therefore postulated that E2f1 destruction during S phase
of the post-blastoderm cell cycles contributes to the termination of E2f1 target gene
expression in the epidermis. To examine this, we visualized E2f1 protein abundance by
immunofluorescence in embryos that were pulse-labeled with BrdU (Figure. 2.3).
E2f1 protein is present throughout the embryo during early syncytial cycles 1-13
(data not shown). Notably unlike imaginal disc cells, nuclear E2f1 was detected during S
phase of cycles 13 and 14 (Figure. 2.3A, B). E2f1 protein accumulates to high levels in the
nucleus during G214 (Figure. 2.3C), and is then rapidly diminished when cells enter S15
(Figure. 2.3D). This effect is post-transcriptional since E2f1 transcripts are ubiquitous during
cycle 15 (Duronio et al., 1995), suggesting that E2f1 protein is destroyed upon entry into S
phase. In addition, the lack of S phase destruction of E2f1 in S13 and S14 suggests that
zygotic gene expression, most of which begins during cycle 14, is necessary for the coupling
of E2f1 destruction with S phase beginning in cycle 15.
E2f1 begins to re-accumulate during G2 of cycle 15, but never attains the levels seen
in G2 of cycle 14 (Figure. 2.3E), perhaps because of the short duration of G215. As in cycle
15, E2f1 protein abundance is low in S16, but begins to re-accumulate in G216 (Figure.
2.3E,F). By the time the epidermal cells enter G117, E2f1 protein has accumulated to a high
level in the nucleus (Figure. 2.3G, H), and remains at this level at least until mid-
embryogenesis (Figure. 2.3I). A group of cells in the first and second thoracic segments do
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Figure 2.3: E2f1 protein accumulation during embryogenesis. w1118 embryos were pulse-labeled with BrdU
for 5 minutes, and stained for E2f1 (green), BrdU incorporation (red) and phospho-tyrosine (cyan). (A)
Embryos undergoing S13. (B) S14. (C) G214. (D) S15 is indicated with arrows; the remaining cells are still in
G214. Note that entry into M14 is not synchronous throughout the embryo, resulting in groups of cells called
mitotic domains that proceed through the cycle coordinately and that generate a reproducible and stereotypic
pattern of BrdU incorporation (e.g. the top arrow indicates mitotic domain 11 (Foe, 1989)). (E) Cycle 15 in the
ventral epidermis (bracket) and S16 in the dorsal epidermis (bar). (F) S16 in the ventral epidermis (bracket) and
G216 -G117 in the dorsal epidermis (bar). Arrowheads in E-H indicate amnioserosa cells. (G, H) Most cells of
the epidermis have entered G117, while, as described in Figure. 2C, some cells continue into cycle 17 (arrows).
(I) G117. Scale bar is 50 µm.
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not enter G117, but instead complete one more division cycle before arresting (Sauer et al.,
1995). E2f1 protein is also down-regulated during S phase in these cells (Figure. 2.3G, H,
arrows). These data indicate that E2f1 protein abundance is inversely correlated with S
phase during the post-blastoderm cell division cycles.
To determine the timing of E2f1 destruction more precisely, we compared E2f1
abundance with the pattern of BrdU incorporation as well as with phospho-histone H3
staining, which detects condensed mitotic chromosomes (Figure. 2.4). As reported for wing
imaginal cells (Reis and Edgar, 2004), E2f1 protein is abundant during mitosis. E2f1 is
nuclear in early prophase prior to nuclear envelope breakdown (Figure. 2.4A, arrowhead). In
metaphase and anaphase, E2f1 protein appears more diffuse, likely due to nuclear envelope
breakdown (Figure. 2.4A, large and small arrows, respectively). E2f1 is present in newly
formed daughter cells, suggesting that it is not destroyed by the APC/C during mitosis
(Figure. 2.4A, double arrow). A high level of E2f1 protein is present in cells in early S
phase, which is characterized by uniform BrdU incorporation throughout the nucleus (Figure.
2.4B, large arrow). In mid-S phase, where BrdU incorporation is less uniform, there is a
significant reduction in E2f1 protein (Figure. 2.4B, small arrow). By late S phase, where the
more punctuate BrdU incorporation pattern marks late replicating heterochromatin, there is
very little E2f1 protein present (Figure. 2.4B, arrowhead). These data are consistent with the
destruction of E2f1 protein after the initiation of S phase, and differs slightly from previous
results in imaginal discs where no overlap between E2f1 staining and BrdU was detected
(Heriche et al., 2003; Reis and Edgar, 2004). This difference may be due to the short
embryonic cell cycle lacking a G1 phase as compared to the canonical G1-S-G2-M disc
cycles.
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Figure 2.4: E2f1 protein persists through mitosis into early S phase. (A) Stage 8 w1118 embryo labeled with
E2f1 (green), phospho-histone H3 (red), and phospho-tyrosine (cyan). Prophase (arrowhead), metaphase (large
arrow), anaphase (small arrow), and daughter cells in early interphase (double arrow) are indicated. (B) Stage
11 w1118 embryo labeled with E2f1 (green), BrdU (red; 5 minute pulse), and phospho-tyrosine (cyan). Early,
mid, and late S phase are marked by a large arrow, a small arrow, and an arrowhead, respectively. Scale bars
are 20µm.
E2f1 staining in E2f1 mutant embryos was indistinguishable from wild type until S14
(data not shown), suggesting that maternal protein persists until S14. E2f1 mutant embryos
contain a detectable amount of E2f1 protein in G214, but this amount is less than sibling
controls (Figure. 2.5A, B), indicating that zygotic E2f1 synthesis is responsible for a portion
of the E2f1 protein found in G214. Zygotic RnrS mRNAs rapidly accumulate in the
epidermis during cycle 14, and then begin to decline during cycle 15 such that by the
beginning of S16 these mRNAs are very low (Figure. 2.1D, arrowhead, Figure. 2.2A, Figure.
2.6). This dynamic pattern of expression is not altered in E2f1 mutant embryos (Figure.
2.5E, F) (Duronio et al., 1995). These data suggest that maternal E2f1 is sufficient to induce
early, zygotic transcription of E2f1 targets, and are consistent with the hypothesis that S
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phase-coupled destruction of E2f1 protein contributes to the decline of E2f1-regulated
transcripts during cycle 15.
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Figure 2.5: Maternal E2f1 protein is present at the onset of zygotic RnrS expression. (A-D) Embryos were
pulse labeled for 5 minutes with BrdU and stained for E2f1 (green), phospho-tyrosine (cyan), and BrdU
incorporation (red). (A) Sibling control at G214. (B) E2f17172/E2f17172 embryo at G214. (C) Sibling control at
G214/S15. (D) E2f17172/E2f17172 embryo at G214/S15. E2f1 mutants were identified by the reduction in E2f1
protein level. (E, F) Embryos were stained for E2f1 (green) and RnrS (red). (E) Sibling control. (F)
E2f17172/E2f17172 embryo. Scale bars are 50 µm.
Figure 2.6: RnrS expression declines during cycles 15 and 16. (A-C) w1118 embryos were pulse-labeled with
BrdU for 15 minutes and stained for BrdU incorporation (green). RnrS expression was detected by FISH (red).
(A) Stage 9 embryo at early S15. (B) Stage 9 embryo. The bracket denotes a region of late S15 and the line
indicates cells in early S15. (C) Stage 10 embryo. The line denotes a region of early S16. Scale bar is 50 µm.
E2f1 protein destruction is S phase-dependent
The correlation between E2f1 disappearance and BrdU labeling suggests that either
cell cycle progression into S phase or DNA synthesis per se triggers E2f1 destruction. To
43
test if entry into S phase is required for the destruction of E2f1, we analyzed E2f1 protein
levels in stg mutants, which arrest in G214 (Edgar and O'Farrell, 1990). E2f1 accumulates to
a high level in the epidermis of stg mutant embryos (Figure. 2.7A). Aminoserosa cells,
which in wild type embryos permanently exit the cell cycle in G214, also accumulate high
levels of E2f1 (Figure. 2.3E-H, arrowheads). In Cyclin E mutants, E2f1 protein is not
destroyed in the thoracic cells that normally enter a 17th division cycle (Figure. 2.3G, H),
because these cells do not enter S phase (data not shown). These data suggest that the
destruction of E2f1 in the epidermis requires entry into S phase.
To test if DNA synthesis is required for E2f1 destruction, we analyzed double-parked
(dup) mutant embryos. dup encodes Drosophila Cdt1, a component of the pre-replication
complex (pre-RC) that is required for eukaryotic DNA synthesis. dup mutant embryos
develop normally through cycle 15, and then display impaired DNA replication in S16
causing cell cycle arrest and embryonic lethality (Garner et al., 2001; Whittaker et al., 2000).
S16 is absent in dupa1 null mutants, whereas dupa3 hypomorphic mutants display weak BrdU
incorporation during a prolonged and partial S16 (Figure. 2.7B, C) (Garner et al., 2001).
dupa1 mutants accumulate high levels of E2f1 in the epidermis, suggesting that DNA
synthesis is necessary for E2f1 destruction (Figure. 2.7B). Interestingly, dupa3 mutants also
accumulate high levels of E2f1 even though these epidermal cells are capable of
incorporating some BrdU (Figure. 2.7C). This suggests that efficient progression through S
phase is necessary to trigger E2f1 destruction, and/or that Dup plays a more direct role in
E2f1 destruction.
S phase-dependent destruction of E2f1 protein predicts that E2f1 levels will be low
during the ectopic S17 that occurs in dap and fzr mutants. This would provide an explanation
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for the lack of E2f1 target gene expression even in the presence of ectopic CycE/Cdk2 that is
predicted to prevent Rbf1 activation (Figure. 2.1I). Indeed, E2f1 protein abundance is low
during ectopic S17 in the epidermis of both dap and fzr mutants (Figure. 2.7D, F,
respectively). Conversely, Dap over-expression results in the accumulation of E2f1 protein
throughout the epidermis, most likely because of the inhibition of S16 (Figure. 2.7E). These
data are consistent with the hypothesis that the initial loss of E2f1 target gene expression
results from the absence of E2f1, rather than from the appearance of hypo-phosphorylated
Rbf1.
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Figure 2.7: E2f1 destruction is replication-dependent. (A-E) Stage 11 embryos were pulse-labeled with
BrdU for 5 minutes, and stained for E2f1 (green), BrdU incorporation (red), and phospho-tyrosine (cyan). (A)
stg7B/stg7B. (B) dupa1/dupa1. (C) dupa3/dupa3. (D) dap4454/dap4454; arrow indicates epithelial cells expressing low
levels of E2f1. (E) UAS dap/arm-Gal4 VP16. (F) Stage 11 Df(1)biD3/Df(1)biD3 fzr were pulse-labeled with
46
BrdU for 15 minutes, and stained with E2f1 (green) and BrdU (red). Arrow indicates epithelial cells expressing
low levels of E2f1 similar to dap mutants. Scale bars are 50 µm.
Rbf1 is not required for the initial termination of E2f1 target gene expression prior to
G117 arrest.
We have demonstrated that E2f1 protein is destroyed during S15 near the time when
RnrS expression begins to decline. This is one cell cycle before Dap is induced to inhibit
CycE/Cdk2 and trigger the onset of G117. If Dap expression and the inhibition of CycE/Cdk2
results in the accumulation of hypo-phosphorylated Rbf1 (Figure. 2.1I), then RnrS expression
is normally terminated before Rbf1 becomes active. This model predicts that RnrS
expression should terminate on schedule in Rbf1 mutant epidermal cells. Indeed, both E2f1
protein and RnrS transcripts are absent during S16 in Rbf1 mutant epidermal cells (Figure.
2.8A). Later, as E2f1 protein re-accumulates throughout the epidermis in G216 and G117,
RnrS transcripts inappropriately reappear in Rbf1 mutants (Figure. 2.8B). This ectopic
expression of E2f1 target genes ultimately results in cell cycle re-entry, as previously
described (Figure. 2.8C, bracket) (Du and Dyson, 1999). Not all Rbf1 mutant epidermal cells
re-enter S phase, suggesting that other inputs modulate the cell cycle response to Rbf1 loss.
This may include cell-by-cell differences in the amount of E2f1, since we observe that cells
with the most E2f1 are usually the same ones that enter S phase inappropriately. This is
consistent with previous observations that transgene-mediated high level E2f1/Dp expression
can drive most of the G117 epidermal cells into S phase (Duronio et al., 1996). These data
indicate that Rbf1 is not required for the initial termination of E2f1 target gene expression,
but rather for sustained termination and stable G1 arrest.
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Figure 2.8: The initial termination of E2f1 target gene expression does not require Rbf1. Rbf114 maternal
and zygotic null embryos were pulse-labeled with BrdU for 15 minutes and stained for E2f1 (green) and BrdU
incorporation (cyan). RnrS expression was detected by FISH (red). (A) Stage 10 embryo; bracket marks the
dorsal epidermis in S16 and the bar indicates cycle 15. (B) Stage 11 embryo; the epidermal cells are in G216. (C)
Stage 13 embryo; arrow indicates epidermal cells arrested in G117 and the bracket denotes epidermal cells
inappropriately incorporating BrdU. Scale bar is 50µm.
Dap expression promotes conversion of Rbf1 to a repressor
While our data suggest that E2f1 target genes are controlled independently of Rbf1
prior to cycle 17, it does not define the mechanism by which Rbf1 is converted to a repressor
during G117. To address this issue, we re-evaluated the inhibition of CycE/Cdk2 activity by
Dap. We hypothesized that developmentally-controlled Dap expression in cycle 16 does
indeed convert Rbf1 to a repressor, but that Rbf1 is not required for the initial shut down of
RnrS because other mechanisms, such as E2f1 destruction in cycles 15 and 16, are sufficient.
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Rather, Rbf1 is required to prevent the reactivation of E2f1 target genes as E2f1 protein re-
accumulates during G216 and G117.
The phenotype of stg mutants allowed us to test this hypothesis. Previous
experiments revealed that E2f1 target gene expression terminates on schedule in stg mutants
even though stg mutant epidermal cells arrest in G214 (Duronio and O'Farrell, 1994). This is
an indication of a developmentally-timed event that occurs independently of cell cycle
progression. The high level of E2f1 protein in stg mutant epidermal cells (Figure. 2.7),
which never enter S phase, would at first seem to be at odds with this result. However,
developmentally controlled Dap expression in a stg mutant may inhibit CycE/Cdk2 and result
in the accumulation of hypo-phosphorylated Rbf1 and the down regulation of E2f1 targets
(Figure. 2.1I) (Meyer et al., 2002b). We therefore simultaneously examined Dap and RnrS
expression in stg mutants. In the epidermis of stg mutants at the normal time of cycle 15 (i.e.
after gastrulation and germ band extension) RnrS transcripts are abundant and Dap protein is
not detected (Figure. 2.9A). Later, when Dap protein accumulates, RnrS expression
decreases (Figure. 2.9B). To test whether loss of RnrS expression in stg mutant embryos
requires Dap, we analyzed stg dap double mutant embryos shortly after the time when Dap is
first induced. RnrS is not suppressed in certain cells of stg dap double mutant embryos that
correspond to cells with high levels of Dap protein in stg single mutant sibling embryos
(Figure. 2.9C, D, bracket). These data are consistent with our model that the inhibition of
CycE/Cdk2 by developmentally-controlled Dap expression results in the accumulation of
Rbf1/E2f1 repressor complexes. However, as stg dap mutant embryos age, RnrS expression
is eventually lost in many epidermal cells (Figure. 2.9E). This also occurs in the
aminoserosa, which contains cells that have exited the cell cycle in G214 (Figure. 2.9D,
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asterisk). These data imply the existence of Rbf1-indepenent mechanisms to extinguish E2f1
target gene expression. Perhaps when cells exit the cycle, Dap-mediated Rbf1 activation
terminates E2f1 target gene transcription while additional mechanisms dramatically decrease
mRNA stability.
Figure 2.9: Dap expression activates Rbf1. Embryos were stained for Dap (green) and phospho-tyrosine
(cyan). RnrS expression was detected by FISH (red). (A) Stage 10 stg7B/stg7B embryo. (B) Stage 12 stg7B/stg7B
embryo. Brackets mark the epidermal cells and asterisks denote G214-arrested aminoserosa cells. (C-E)
Embryos from dap4454/+; stg7B/+ parents. (C) Stage 11 embryo with stg7B/stg7B phenotype. (D) Stage 11
dap4454/dap4454; stg7B/stg7B embryo. C and D are siblings that are stage-matched based on age, morphology and
phospho-tyrosine staining. Bracket in C indicates epidermal cells in which RnrS is starting to decline and Dap
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is expressed at high levels. Bracket in D shows the corresponding region in which RnrS levels remain high.
Asterisk in D denotes aminoserosa cells. (E) Stage 12 dap4454/dap4454; stg7B/stg7B embryo. Scale bar is 50µm.
Inefficient Rbf1 activation in dup mutants
For reasons that are unclear, dup mutants fail to terminate E2f1-dependent
transcription in the epidermis (Whittaker et al., 2000). dupa1 mutant epidermal cells fail to
down-regulate RnrS at the time of S16, and dupa3 mutants still express RnrS during the
prolonged and partial S16 (Figure. 2.10A-C). This may be explained by the high level of
E2f1 protein that accumulates in dup mutants (Figure. 2.7). However, Dap protein
accumulates during cycle 16 in dup mutants (data not shown), and this should result in the
down-regulation of E2f1 targets as in stg mutants. Rbf-280 expression using the prd-Gal4
driver suppressed the ectopic RnrS expression in dupa1 mutants, suggesting that E2f1 can still
be repressed by hypo-phosphorylated Rbf1 in dup mutants (Figure. 2.10D-G). At later
stages, RnrS transcripts eventually begin to decline in dup mutants (data not shown). We
suggest that in dup mutants Rbf1 is still converted to an active, hypo-phosphorylated form in
response to Dap expression, but that the termination of E2f1-dependent transcription occurs
slowly because of the abnormally high level of E2f1 protein.
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Figure 2.10: E2f1 target gene expression persists inappropriately in dup mutants. (A-C) Stage 11 embryos
were pulse-labeled with BrdU for 5 minutes, and stained for BrdU incorporation (green), and phospho-tyrosine
(cyan). RnrS expression was detected by FISH (red). (A) w1118. (B) dupa1/dupa1. (C) dupa3/dupa3. (D-G)
Histochemical detection of RnrS expression by in situ hybridization of dupa3 embryos (F) or embryos from
dupa1/+; UAS Rbf-280/+ females crossed to dupa1/+; prd-Gal4/+ males (D, E and G). (D) Sibling control
embryo. (E) Embryo with dupa1/dupa1 phenotype. (F) dupa3/dupa3 embryo. (G) dupa1/dupa1; UAS Rbf-
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280/prd-Gal4 embryo. UAS Rbf-280 expression suppresses ectopic RnrS caused by dup mutation (arrow).
Scale bar in A-C is 50 µm
Discussion
Our finding that p27Dap expression was not necessary for the down regulation of
E2f1 targets was unexpected based on the known regulatory circuitry of the pRb/E2F
pathway (Figure. 2.1I). This result led us to hypothesize that mechanisms in addition to Rbf1
binding were used to control E2f1 activity in the early embryo. We found that E2f1 is
destroyed during S phase of the post-blastoderm divisions in the embryonic epidermis, as
was previously reported for cells in wing and eye imaginal discs (Asano et al., 1996; Heriche
et al., 2003; Reis and Edgar, 2004). E2f1 destruction first occurs during S15 at the same time
that E2f1-regulated transcripts like RnrS begin to decline. Because E2f1 functions as a
transcriptional activator, and because we show that Rbf1 is not required for the initial decline
in RnrS transcripts, we propose that the loss of E2f1 protein contributes to the initial
termination of replication factor gene expression. Rbf1 is first required during development
for the maintenance of G117 arrest and the continued repression of E2f1 target genes. Our
data suggest that Rbf1 is converted to a repressor after the developmentally-induced
expression of Dap, most likely because the consequent inhibition of CycE/Cdk2 results in the
accumulation of hypo-phosphorylated Rbf1. Dap expression accompanies the down
regulation of Cyclin E transcription, and each of these mechanisms of CycE/Cdk2 inhibition
contributes to G1 arrest.
The high level of E2f1 protein in G117 epidermal cells may permit the formation of
E2f1-Rbf1 complexes necessary to actively and stably repress replication factor genes during
G1 arrest (Frolov and Dyson, 2004), and also provides a simple explanation for why the loss
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of Rbf1 function results in the ectopic expression of E2f1 targets (Du and Dyson, 1999).
After hatching, and in response to the first instar larvae beginning to feed, the epidermal cells
start to endoreduplicate. Thus, the accumulation of Rbf1/E2f1 complexes during G1 arrest
may prepare cells for rapid production of replication factors and efficient re-entry into the
cell cycle upon activation of G1 Cyclin/Cdk complexes after growth stimulation.
RnrS expression is lost in E2f1 zygotic mutant embryos, but not until cell cycle 17
(Duronio et al., 1995). One interpretation of this result is that maternal stores of E2f1 are
sufficient for the early induction of replication gene expression in the post-blastoderm
divisions. Consistent with this, maternal E2f1 protein persists into cycle 14 coincident with
the commencement of zygotic transcription of E2f1 targets like RnrS. In addition, mutation
of the E2f1-binding sites in the regulatory region of the PCNA gene is sufficient to abolish
zygotic PCNA expression (Thacker et al., 2003). However, our data do not demonstrate an
E2f1 requirement for early zygotic RnrS expression, and E2f1 may be only one of several
factors necessary for early zygotic expression of genes encoding replication factors (Hirose et
al., 1993; Sawado et al., 1998; Yamaguchi et al., 1996). For instance, the transcription of
Cyclin E requires E2f1 in embryonic endocycles, but also occurs independently of E2f1 via
tissue-specific enhancer elements such as those operating in the CNS (Duronio and O'Farrell,
1995; Jones et al., 2000). Thus, any control of replication factor gene expression by E2f1
abundance may be modulated by other transcription factors, or bypassed entirely in certain
cell types by E2f1-independent modes of expression.
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Mechanisms of cell cycle-regulated E2f1 destruction
Our data suggest that E2f1 destruction is coupled to DNA synthesis. CycE/Cdk2 has
been suggested as a possible cell cycle input for E2f1 destruction in imaginal cells, because it
is activated at the G1-S transition when E2f1 is destroyed (Heriche et al., 2003; Reis and
Edgar, 2004). However, CycE/Cdk2 is continuously active during the embryonic post-
blastoderm cell cycles whereas E2f1 is destroyed only during S phase (Sauer et al., 1995).
Thus, CycE/Cdk2 is unlikely to be the only signal, and actively replicating DNA may
provide a necessary input into E2f1 destruction. This model is consistent with our
observation that E2f1 destruction occurs after DNA synthesis begins, resulting in cells that
are positive for both E2f1 and BrdU incorporation in early interphase.
Previous studies have suggested that mammalian E2f1 is degraded by the ubiquitin-
proteasome pathway (Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et
al., 1996; Marti et al., 1999; Ohta and Xiong, 2001). In this pathway, E3 ubiquitin ligases
bind to and mediate the ubiquitylation of specific proteins. The SCF class of cullin-
dependent E3 ligases has been implicated in E2F1 destruction (Marti et al., 1999). In
Drosophila, genetic and cell biological evidence suggest that SCFSLMB mediates E2f1
destruction at the G1/S transition in wing imaginal disc cells (Heriche et al., 2003). While
there is no evidence implicating a specific E3 ligase in the destruction of embryonic E2f1,
there are interesting parallels with recent experiments describing the destruction of
Cdt1/Dup. Like E2f1, Cdt1/Dup is degraded at the G1-S transition and cannot be detected
during S phase (Thomer et al., 2004). In vertebrates, Cdt1 destruction is mediated by two
independent and apparently redundant mechanisms: direct Cdk2 phosphorylation that targets
Cdt1 to SCFSKP2, and binding of PCNA to the Cdt1/Dup NH2-terminus that targets Cdt1 to
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Cul4DDB1 (Arias and Walter, 2006; Nishitani et al., 2006; Senga et al., 2006). This latter
result is consistent with a recent study indicating that Drosophila Dup hyper-accumulates in
cells where DNA synthesis is attenuated (May et al., 2005). Thus, more than one E3
ubiquitin ligase may participate in E2f1 destruction (Ohta and Xiong, 2001). Determining
the molecular mechanism of E2f1 destruction should permit us to directly test whether
prevention of E2f1 destruction would affect replication factor gene expression in the embryo.
pRb-independent E2F regulation and early animal development
E2F is necessary for the development of worms, flies and mice (DeGregori, 2002).
Remarkably, however, pRb is not needed for the entirety of mouse embryonic development
(Wu et al., 2003). This could be due in part to redundancy with other pRb family members,
such as p107 and p130 (Dannenberg et al., 2004). Alternatively, a pRb-independent
mechanism of regulating E2F activity may control S phase gene expression and cell cycle
progression during early mammalian development. This idea is supported by experiments
modeling the cell cycles of early vertebrate development in cell culture using murine
embryonic stem (ES) cells (White et al., 2005). These pluripotent cells have a cell cycle
composed mostly of S phase that is characterized by ubiquitous Cdk activity and the absence
of CKIs (Faast et al., 2004; Savatier et al., 1996; Stead et al., 2002). As in the Drosophila
embryo, E2F-regulated transcripts are also ubiquitous even though pRb family members are
expressed (Savatier et al., 1994; Stead et al., 2002). Differentiation requires the lengthening
of G1 and the negative regulation of Cdk2 activity, which is accomplished both by increases
in the level of CKIs and by the down-regulation of Cyclin E1 expression via inhibition of
E2F (White et al., 2005). Thus, evolutionarily conserved regulatory mechanisms operating in
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early development may mediate the conversion from rapid cell cycles driven by intrinsic cues
to slower, more highly regulated cycles that are influenced by extrinsic developmental and
environmental cues.
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TYPE 1 PROTEIN PHOSPHATASE MUTANTS
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Abstract
G1 Cyclin/Cdk complexes phosphorylate and inactivate the pRb tumor suppressor by
preventing its ability to bind and repress E2F transcription factors. Current molecular and
biochemical evidence suggests that type 1 protein phosphatases (PP1) dephosphorylate and
thereby activate pRb, but the functional significance of this has not been addressed in the
context of animal development. Here, we use genetic analyses to determine the role of PP1
in the regulation of Rbf1 activity during Drosophila development. While Rbf1 is required
for E2f1 inhibition and G1 arrest in the embryonic epidermis and for the periodic expression
of E2f1 target genes during endocycle S phase in the embryonic midgut and larval salivary
gland, PP1 is not. PP1 regulates periodic cyclin E protein accumulation in ovarian nurse
cells independently of Rbf1, which is dispensable for endocycle regulation in this tissue. We
conclude that PP1 is not a major regulator of the Rbf1/E2F1 pathway in Drosophila.
Introduction
As one of the earliest tumor suppressors described, pRb has a well-established role in
cell cycle control during development. pRb inhibits the activity of the E2f transcription
factor, which regulates many genes that contribute to cell cycle progression (DeGregori,
2002; Dimova and Dyson, 2005; Trimarchi and Lees, 2002). pRb activity with respect to E2f
is controlled by phosphorylation. Hypo-phosphorylated pRb binds E2f and represses gene
expression. Upon phosphorylation by G1 Cyclin/Cyclin-dependent kinase (Cyc/Cdk)
complexes, including Cyclin D/Cdk4 (CycD/Cdk4) and Cyclin E/Cdk2 (CycE/Cdk2), pRb
dissociates from E2f, which then activates the transcription of target genes that contribute to
S phase entry.
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While large efforts have been made to characterize the kinases responsible for pRb
phosphorylation, less is known about the phosphatases that contribute to pRb
dephosphorylation. In the current view, various Cyc/Cdk complexes maintain pRb in a
hyper-phosphorylated state throughout much of the cell cycle, and hypo-phosphorylated pRb
accumulates during mitosis beginning in anaphase (Tamrakar et al., 2000). There is some
evidence that type 1 protein phosphatases (PP1) directly mediate pRb dephosphorylation
(Alberts et al., 1993; Ludlow et al., 1993; Nelson et al., 1997; Nelson and Ludlow, 1997; Yan
and Mumby, 1999). pRb associates with PP1 both in vitro and in vivo (Durfee et al., 1993;
Nelson et al., 1997; Puntoni and Villa-Moruzzi, 1997), and this association occurs through
the C-terminal region of pRb (Tamrakar and Ludlow, 2000). Interestingly, PP1 interacts
with both hyperphosphorylated and hypophosphorylated pRb (Nelson and Ludlow, 1997;
Tamrakar et al., 1999). CycD/Cdk4 and CycE/Cdk2 phosphorylate pRb at different residues,
and some experiments suggest that the dephosphorylation of these residues is site-specific
and temporally-regulated (Rubin et al., 2001). Although there are multiple PP1 isoforms in
mammalian cells (Ceulemans and Bollen, 2004), PP1 appears to be the most active toward
pRb (Nelson et al., 1997; Rubin et al., 2001).
Although the relationship between PP1 and pRb has been extensively characterized at
the molecular level in mammalian cell culture, it has not been analyzed in the context of
animal development where genetic means can assess the contribution of PP1 activity to pRb
function and E2f target gene expression in vivo. To address this, we used phenotypic
analysis of Drosophila PP1 mutations to explore the role of PP1 in pRb regulation during
development. As in mammals, the pRb homolog in Drosophila (Rbf1) that regulates cell
cycle-coupled gene expression is controlled by phosphorylation (Du et al., 1996). Rbf1
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negatively regulates the E2f1 transcription factor, which is required for replication factor
gene expression (Du and Dyson, 1999; Duronio et al., 1995; Royzman et al., 1997). The
Rbf1/E2f1 network functions throughout development, including during G1 cell cycle exit
(Du and Dyson, 1999; Shibutani et al., 2007),the proliferation of diploid imaginal cells (Xin
et al., 2002), and the regulation of the non-canonical endocycle, in which cells become
polyploid through repeated rounds of S phase that are not interrupted by mitosis (Duronio et
al., 1998; Royzman et al., 2002; Weng et al., 2003). Drosophila thus provides a unique
opportunity to analyze the contribution of PP1 to Rbf1/E2f1 control in various situations.
PP1 is an evolutionarily well-conserved protein that has been implicated in a number
of processes including glycogen metabolism, mitosis, muscle contraction, and RNA
processing (Cohen, 2002). It exists as a holoenzyme composed of a regulatory subunit and a
catalytic subunit (Ceulemans and Bollen, 2004). In Drosophila, there are two subtypes of
PP1 catalytic subunits: PP1, which is homologous to mammalian PP1 and PP1, and
PP1, which is homologous to mammalian PP1/ (Dombradi et al., 1993). While there are
three genes that encode PP1-isozymes (PP113C, PP187B, and PP196A), there is only
one gene that encodes for PP1 (PP19C or flw). Although the protein sequences of PP1
and PP1 are very similar, each subtype appears to have a unique function in the fly
(Dombradi et al., 1993). PP19C specifically regulates non-muscle myosin (Vereshchagina
et al., 2004), although PP196A may participate in this process (Kirchner et al., 2007), while
PP187B has been implicated in mitotic progression and acts as a suppressor of position-
effect variegation (Axton et al., 1990; Baksa et al., 1993; Dombradi et al., 1990).
Rbf1 activity is highly regulated during Drosophila development. In the early
embryo, Rbf1 is expressed but kept inactive presumably by hyper-phosphorylation via
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constitutively active CycE/Cdk2, and this results in the ubiquitous transcription of E2f1-
target genes (Shibutani et al., 2007). Later in embryogenesis, when epidermal cells exit the
cell cycle and arrest in G1, Rbf1 is required to repress E2f1-target gene expression (Du and
Dyson, 1999; Shibutani et al., 2007). The mechanisms by which Rbf1 is converted to an
active inhibitor of E2f1 as cells initially exit the cell cycle remain incompletely understood,
but presumably involve a conversion of Rbf1 from a hyper- to a hypo-phosphorylated form
(Shibutani et al., 2007). Rbf1 also functions to regulate the endocycle: chronic E2f1 activity
in the absence of Rbf1 activity reduces the ploidy of many larval tissues (Weng et al., 2003),
likely because periodic expression of E2f1 targets like Cyclin E is necessary for re-activation
of replication origins during each endocycle S phase (Follette et al., 1998; Lilly and Duronio,
2005; Weiss et al., 1998).
By analyzing PP1 catalytic subunit mutants, we asked whether PP1 activity
modulates Rbf1 activity during cell cycle exit and endocycle progression in vivo. Our data
indicate that the expression of Rbf1/E2f1-regulated genes is unchanged in PP1 mutant
embryonic cells that have exited the cell cycle in G1 and in endocycling cells of the
embryonic midgut and the larval salivary gland. However, we have identified a role for PP1
in the regulation of the endocycle in ovarian nurse cells.
Materials and Methods
Drosophila strains
w
1
, w
1118
, AB1-Gal4, actin-Gal4/TM6B, da-Gal4, midgut-Gal4, w ovoD FRT 14A-
B/C(1)DX, y f/Y; hsFLP, hsFLP, y w; DrMio/TM3, w; FRT 82B, piM 87E, w; FRT 82B ovoD/
st  Tub85D ss e/TM3, In(1)wm4h; PP187B1/TM3, w; Df(3R)Exel 6164/TM6B, w1118;
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Df(3R)Exel 7357/TM6B, and Df(1)ED7294, w1118/FM7j, B were obtained from the
Bloomington Stock Center. dap4454/CyO has been described previously (Lane et al., 1996).
UAS HA-PP187B/TM3, UAS HA-NIPP1Dm/TM6B, PP196A2 e/TM6B, and PP187B87Bg-
3
-PP196A2 e /TM6B were generously provided by Luke Alphey (Bennett et al., 2003;
Kirchner et al., 2007; Vereshchagina et al., 2004). UAS Rbf-280/TM3, UAS Rbf1, and
Rbf114 FRT14A-B/FM7 as well as w; PP187B87Bg-3/TM6B and w; PP187B87Bg-6 e/TM6B
were kindly provided by Wei Du and Adelaide Carpenter, respectively (Axton et al., 1990;
Du and Dyson, 1999; Xin et al., 2002). w1118; PCNA EmGFP, dap4454/CyO wg-lacZ, w;
PP187B87Bg-6-PCNA EmGFP e /TM3 kr-GFP, w; PP187B87Bg-3-PCNA EmGFP/TM3 kr-
GFP, PP187B1-PP196A2/TM3 twi-GFP, PP187B87 Bg-6-Df(3R)Exel 7357/TM6B, and
hsFLP y w; PP187B1 FRT82B/TM3 were constructed for this study. Rbf114 and PP187B1
germ line clones were generated as described (Du and Dyson, 1999). PP113C, PP187B,
and PP196A triple mutants were constructed by crossing Df(1)ED7294/+; PP187B87 Bg-3-
PP196A2/+ females with either PP187B87 Bg-3-PP196A2/TM3 twi-GFP or PP187B87 Bg-6-
Df(3R)Exel 7357/TM6B males. In total, over 1000 embryos from these parents were
analyzed for RnrS expression and over 500 for BrdU incorporation.
PCNA EmGFP transgene construction
A modified version of the PCNA-GFP fusion construct reported in Thacker, et al.,
2003 (Thacker et al., 2003) was constructed by replacing one copy of GFP with three copies
of Emerald GFP (pUAST::3X Emerald GFP plasmid kindly provided by Chris Doe).
Transgenic animals were created by P-element-mediated germline transformation of a w1
strain.
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RNA in situ hybridization and BrdU labeling
Embryos were dechorionated, fixed in a 1:1 mixture of 4% formaldehyde in
PBS/heptane for 25 minutes, and devitellinized with methanol. For BrdU labeling,
dechorionated embryos were permeabilized with octane, pulse-labeled with 1mg/ml BrdU for
15 minutes in Schneider’s Drosophila medium prior to fixation. Embryos were stored in
methanol at -20˚C.
In situ hybridization with digoxigenin-labeled antisense RNA probes was performed
as described (Kearney et al., 2004). Fluorescent detection of hybrids (FISH) was achieved
with the TSA Fluorescence System (Perkin Elmer) using a 30 minute incubation in TSA-Cy3
or TSA-Fluorescein. For all triple fluorescent staining (i.e. FISH, anti-protein, anti-BrdU)
embryos were first processed for FISH, then for immuno-detection of proteins, and finally
for BrdU detection by acid denaturation of chromosomes (Schubiger and Palka, 1987).
Immunostaining
Ovaries were dissected in Schneider’s Drosophila medium and fixed in a 1:4 mixture
of 2% paraformaldehyde in PBS/heptane for 20 minutes. Larval salivary glands were
dissected in PBS and fixed in 4% formaldehyde in PBS for 20 minutes. Both tissues were
incubated with primary antibody overnight at 4°C. Primary antibodies were: mouse anti-
BrdU monoclonal antibody (1:100, Becton Dickinson), rat anti-BrdU monoclonal antibody
(1:100, Abcam), rabbit anti- galactosidase (1:200, Chemicon), rabbit anti-GFP (1:2000,
Abcam), mouse anti-HA (1:50, Covance), and mouse anti-CycE (1:5, gift of Helena
Richardson) (Richardson et al., 1995). Secondary antibodies were: goat anti-mouse Oregon
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Green (1:1000, Molecular Probes), goat anti-mouse-Cy5 (1:500, Jackson), goat anti-mouse-
Cy3 (1:500, Jackson), donkey anti-rat-Cy5 (1:500, Jackson), and goat anti-rabbit-Cy2 (1:500,
Jackson). Filamentous actin was detected in ovaries by incubation with Oregon green-
conjugated phalloidin (1:1000 in PBS, Invitrogen) for 20 minutes, and DNA in both salivary
glands and ovaries was labeled with DAPI (1:1000, Pierce). A student’s t-test assuming
unequal variances was used for statistical calculations of cyclin E positive nurse cell nuclei.
An unpaired t-test with Welch correction was used to analyze cyclin E and PCNA-EmGFP
positive nuclei in salivary glands. Stained embryos, salivary glands, and ovaries were
mounted with Fluoromount-G (Southern Biotech) and visualized with either a Nikon Eclipse
E800 microscope (for DIC imaging in Figure 1) or a Zeiss LSM 510 scanning confocal
microscope.
Co-immunoprecipitations and western blotting
Immunoprecipitations from 0-8 hour and 8-16 hour actin-Gal4 UAS HA-PP187B
and w1118 embryos were performed as described (Peifer et al., 1993), and analyzed by SDS-
PAGE (4-15% pre-cast gradient gel, Biorad) and western blotting with mouse anti-Rbf1
(DX-3, 1:4; (Du et al., 1996) and mouse anti-HA (1:1000, Covance). The secondary
antibody was ECL™-Sheep anti-mouse HRP (1:5000 for Rbf1 and 1:2000 for HA) from
Amersham Biosciences.
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Results
PP1 catalytic subunits are expressed in the same embryonic cells as Rbf1
We began our analysis by examining PP1 catalytic subunit expression during
embryogenesis. If PP1 regulates Rbf1, then it should be expressed in the same cells as Rbf1.
We examined PP113C, PP187B, and PP196A expression during embryogenesis by in
situ hybridization. mRNA for each PP1 catalytic subunit is provided maternally (Figure
3.1A,E, and I), and is ubiquitously expressed in germ band-extended embryos (Figure
3.1B,F,and J). Following germ band retraction, all three PP1 catalytic subunits are expressed
in the G1-arrested epidermis (Figure 3.1C,G, and K, arrows), the proliferating CNS (Figure
3.1D,H, and L, double arrows), and the endocycling midgut (Figure 3.1D,H, and L,
arrowheads), all tissues where Rbf1 is also expressed (Keller et al., 2005; Stevaux et al.,
2002). PP187B is the most highly expressed of these three catalytic subunits, and this is
consistent with it comprising approximately 80% of total PP1 activity in Drosophila
(Dombradi et al., 1990). PP196A expression is less robust while PP113C expression is
barely detectable, similar to previous observations (Dombradi et al., 1993). Unlike the PP1
isoforms, PP19C has a restricted pattern of expression. PP19C mRNA is provided
maternally, but is not expressed in germ band-extended embryos and zygotic expression is
limited to the musculature in germ band-retracted embryos (BDGP, Gene Expression
Patterns). This expression data is consistent with the possibility that PP113C, PP187B,
and PP196A could regulate Rbf1 in the embryo.
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Figure 3.1: Embryonic expression patterns of Drosophila PP1 catalytic subunits. Whole mount in situ
hybridization of w1118 embryos with PP113C (A-D), PP187B (E-H), and PP196A (I-L) probes. Note
expression in the epidermis (arrows), central nervous system (double arrows), and the midgut (arrowheads).
PP1 is not required for Rbf1-dependent repression of E2f1 target genes in G1-arrested
epidermal cells
Drosophila embryos execute a stereotyped, developmentally-controlled cell cycle
program that is well-characterized (Lee and Orr-Weaver, 2003). The earliest cell cycles lack
G1 phase, with S phase beginning immediately after mitosis. The first G1 appears at the
beginning of germ band retraction, after which many cells remain arrested in G1 (e.g. cells of
the epidermis) while others (e.g. midgut) re-enter S phase and begin endocycles. Rbf1 has an
established role in E2f1 repression and the maintenance of G1 arrest in the embryonic
epidermis (Du and Dyson, 1999). This can be visualized in whole mount preparations of
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embryos that are both labeled with BrdU to detect S phase nuclei and hybridized with a probe
for RnrS, a well-characterized E2f1-target gene encoding the small subunit of ribonucleotide
reductase (Duronio et al., 1995; Shibutani et al., 2007). In wild type germ band-retracted
embryos, G1-arrested epidermal cells do not incorporate BrdU and do not express RnrS
(Figure 3.2A, asterisk). In contrast, Rbf1 mutant embryos (lacking maternal and zygotic gene
function) inappropriately express RnrS throughout the epidermis, indicative of ectopic E2f1
activity, and contain cells that have re-entered the cell cycle as measured by ectopic BrdU
incorporation (Figure 3.2B, asterisk).
Although Rbf1 transcript and protein are present throughout early embryogenesis
(Keller et al., 2005; Stevaux et al., 2002), Rbf1 does not act to repress E2f1-target gene
expression in the epidermis until cells begin to enter G1 arrest during germ band retraction.
We recently provided genetic evidence that the appearance of Rbf1 repressor activity
involves a conversion of Rbf1 from a hyper- to a hypo-phosphorylated form (Shibutani et al.,
2007). To determine if PP1 is involved in this conversion, we analyzed E2f1-target gene
expression and BrdU incorporation in PP1-mutant embryos. We hypothesized that if PP1
was required for Rbf1 dephosphorylation (and thus activation as an E2f1 repressor) then
PP1-mutant embryos would phenocopy Rbf1-mutant embryos and display ectopic RnrS
expression and BrdU incorporation in the epidermis. Initially we analyzed embryos that
were both maternally and zygotically-mutant for PP187B, the major PP1 catalytic subunit
in Drosophila (Dombradi et al., 1990). These embryos were generated with the hypomorphic
PP187B1 allele because we were unable to obtain eggs from mothers with a PP187B null
mutant germ line. PP187B1 is a G-to-A point mutations that results in the conversion of
Gly220 to Ser (Dombradi and Cohen, 1992). Although the reduction in PP187B activity in
75
PP187B1 is similar to the reduction seen in null mutants, this allele was designated a
hypomorph because a transcript is made and there are fewer aberrant mitotic figures seen in
larval neuroblasts compared to null mutants (Axton et al., 1990; Baksa et al., 1993). Unlike
Rbf1 mutants, there was no inappropriate expression of RnrS or ectopic BrdU incorporation
in the epidermis of PP187B1 mutant embryos (Figure 3.2C, asterisk). The same result was
obtained by using null mutant alleles to remove the zygotic contribution of PP187B,
PP113C, or PP196A (data not shown).
The high degree of sequence identity among these three catalytic subunits (Dombradi
et al., 1993) and their similar embryonic expression patterns (Figure 3.1) suggest that they
could function redundantly in Rbf1 control. To address this, we analyzed RnrS expression
and BrdU incorporation in embryos multiply mutant for zygotic gene function. There was no
inappropriate expression of RnrS and no ectopic BrdU incorporation in the epidermis of
either PP187B-PP196A double mutant embryos (Figure 3.2D, asterisk) or PP113C;
PP187B-PP196A triple mutant embryos (see methods). These data suggest that the
removal of the zygotic contribution of PP113C, PP187B, and PP196A does not affect
Rbf1 activity in the embryonic epidermis. To confirm this result, we over-expressed NIPP1
in the epidermis. NIPP1 is an inhibitor of PP1 that when over-expressed results in
phenotypes similar to PP1 mutants (Bennett et al., 2003; Parker et al., 2002). HA-tagged
NIPP1 was expressed throughout the epidermis with the strong, ubiquitous da-Gal4 driver.
In spite of the strong expression of HA-NIPP1 (Figure 3.2E, asterisk), we could not detect
ectopic RnrS expression or BrdU incorporation. Although we cannot be certain that we have
completely eliminated PP1 function in the embryo, these results suggest that Rbf1 is capable
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Figure 3.2: PP1 does not regulate Rbf1 activity in the embryonic epidermis.
(A-D) Stage 14 embryos pulse-labeled for 15 min with BrdU (cyan) were hybridized with an RnrS probe (red).
Asterisks mark the epidermis. Scale Bars are 50µm. (A) w1118. The arrow marks wild type RnrS expression in
the malphigian tubules. (B) Rbf114 maternal and zygotic null embryo. Note the ectopic RnrS expression and
BrdU incorporation in the epidermis. (C) PP187B1/PP187B87Bg-3-PCNA EmGFP maternal and zygotic null
embryo. (D) PP187B87Bg-3-PP196A2/PP187B87Bg-3-PP196A2. The arrow and arrowhead in C and D denote
wild type RnrS expression in the malphigian tubules and trachea, respectively. (E) Stage 14 UAS HA-
NIPP1Dm/da-Gal4 embryo pulse-labeled for 15 min with BrdU (cyan) and hybridized with an RnrS probe (red)
and stained for HA-NIPP1 (green). Note the HA-NIPP1 expression throughout the epidermis. The arrow and
arrowhead denote wild type RnrS expression in the malphigian tubules and trachea, respectively. Scale Bar is
50µm. The embryos in panels A-E are oriented dorsal-laterally with the plane of focus on the epidermis.
Consequently, the replicating cells of the central nervous system are not visible (but see Fig. 3). (F) Schematic
of interactions among G1-S regulators in Drosophila.
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of maintaining G1 arrest, through the inhibition of E2f1-target gene expression,
independently of type 1 protein phosphatase activity.
Another potential mechanism by which Rbf1 activation could occur is through the
inhibition of the Rbf1 kinase CycE/Cdk2, which is constitutively active early in
embryogenesis (Sauer et al., 1995; Xin et al., 2002). We previously showed that in some
cells entering G1 arrest Rbf1 becomes activated by the developmentally controlled
expression of p27Dap, a specific inhibitor of CycE/Cdk2 (de Nooij et al., 1996; Lane et al.,
1996; Shibutani et al., 2007). To test the possibility that p27Dap and PP1 cooperate in the
appearance of active Rbf1, we analyzed RnrS expression and BrdU incorporation in germ
band-retracted, p27Dap; PP187B double zygotic mutant embryos. Similar to germ band-
retracted p27Dap single mutants, there was no inappropriate expression of RnrS in the
epidermis and no ectopic BrdU incorporation (de Nooij et al., 1996; Lane et al., 1996)
suggesting that these pathways do not act redundantly.
Figure 3.3: Dap and PP187B do not act redundantly to regulate embryonic Rbf1 activity.
(A-B) dap4454;PP187B1-PCNA EmGFP double mutant embryos were generated by crossing
dap4454/+;PP187B1-PCNA EmGFP/+ males and females. Stage 14 embryos were pulse labeled for 15 min
with BrdU (cyan), hybridized with an RnrS probe (red), and stained with anti-GFP (not shown). GFP staining
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confirmed the PP187B1-PCNA EmGFP chromosome. (A) Epidermal View. (B) Internal View. Arrows
denote the anterior and posterior midgut.
Rbf1 regulates embryonic midgut endocycles
Although we could not detect a role for PP1 during G1 cell cycle exit in the
embryonic epidermis, PP1 could regulate Rbf1 in cycling cells. We therefore chose to
examine an endocycling cell population, because periodic S phase-coupled expression of
E2f1-target genes contributes to normal endocycle progression (Duronio et al., 1998).
Following G1 arrest, cells of the midgut re-enter S phase and begin endocycles, where gap
phase and S phase alternate (Lee and Orr-Weaver, 2003). Separate regions of the embryonic
midgut differentially enter and exit S phase, generating a characteristic pattern of coincident
BrdU incorporation and RnrS expression. For example, during stage 14 the central midgut
cells are in S phase and therefore incorporate BrdU and express RnrS (Figure 3.4A, arrow),
while the anterior and posterior midgut cells are in a gap phase and do not incorporate BrdU
nor express RnrS (Figure 3.4A, arrowheads).
Previous experiments suggested that Rbf1 is necessary for normal midgut endocycle
regulation (Du and Dyson, 1999). To examine this, we analyzed RnrS expression and BrdU
incorporation in stage 14 embryos lacking maternal and zygotic Rbf1. In a Rbf1 mutant
embryo, both BrdU incorporation and RnrS expression occur throughout the midgut rather
than just in the central midgut as seen in a wild type embryo (compare Figure 3.4B to 3.4A).
The increase in BrdU positive cells in the anterior and posterior midgut (arrowheads in
Figure 3.4B) at this stage suggests that Rbf1 mutant cells spend less time in the endocycle
gap phase (i.e. the gap phases are shorter). It is difficult to precisely determine whether the
cells of the anterior and posterior midgut re-enter S phase precociously or whether they fail
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to exit the previous S phase on schedule. Regardless, these results suggest that the control of
E2f1 activity by Rbf1 is required for the proper regulation of the endocycle in the midgut.
To test whether Rbf1 activity was controlled by phosphorylation in the midgut, we
utilized a mutant version of Rbf1 (Rbf-280) containing mutations in four Cdk consensus sites
that cannot be inhibited by the activity of G1 Cyc/Cdk complexes (e.g. CycE/Cdk2) (Xin et
al., 2002). Driving UAS Rbf-280 expression with a midgut-specific driver resulted in the
termination of RnrS expression in the central midgut (compare Figure 3.4E to 3.4C, arrows).
Little change was seen after the over-expression of wild type Rbf1 (Figure 3.4D, arrow),
suggesting that the termination of RnrS was specific to UAS Rbf-280. These results suggest
that Rbf-280 can bypass the normal mechanism of Rbf1 control in the embryo, and are
consistent with Rbf1 activity being regulated by phosphorylation in the endocycling midgut.
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Figure 3.4: Rbf1 and Dap regulate the embryonic midgut endocycle independently of PP1.
(A-B) Stage 14 embryos pulse-labeled for 15 min with BrdU (cyan) and hybridized with an RnrS probe (red).
(A) w1118. (B) Rbf114 maternal and zygotic null embryo. (C-E) In situ hybridization of stage 13 embryos with
an RnrS probe. Arrows denote the central midgut. (C) w1118. (D) UAS Rbf1/midgut-Gal4. (E) UAS Rbf-
280/midgut-Gal4. (F-I) Stage 14 embryos pulse labeled for 15 min with BrdU (cyan), hybridized with an RnrS
probe (red), and stained with either anti-GFP (not shown), anti--galactosidase (not shown), or anti-HA
antibodies (green). (F) PP187B1/PP187B87Bg-3-PCNA EmGFP maternal and zygotic null embryo. GFP
staining confirmed the PP187B87Bg-3-PCNA EmGFP chromosome. (G) PP187B87Bg-3-
PP196A2/PP187B87Bg-3-PP196A2. The absence of GFP staining from the balancer chromosome indicated
PP187B-PP196A double mutant embryos. (H) UAS HA-NIPP1Dm/midgut-Gal4. HA staining confirmed
HA-NIPP1 expression in the midgut. The double arrow denotes the anterior and posterior midgut while the
asterisk (RnrS panel) marks yolk autofluorescence. (I) dap4454/dap4454. The absence of -galactosidase staining
from the balancer chromosome indicated dap mutant embryos. In panels A, B, F, G and I the arrow indicates
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the central midgut and the arrowheads indicate the anterior and posterior midgut. Note that in these embryos,
expression of RnrS and incorporation of BrdU are unaffected in the central nervous system (small arrow). Scale
Bar is 50µm.
Type 1 protein phosphatases do not regulate Rbf1 activity in the endocycling midgut
To test if PP1 modulates Rbf1 activity in the midgut, we analyzed RnrS expression
and BrdU incorporation in PP1 mutants. We hypothesized that if PP1 was involved in the
dephosphorylation of Rbf1 and thus activation of Rbf1 repressor activity in the midgut, then
PP1-mutant embryos would have the same phenotype as Rbf1-mutant embryos. However,
unlike Rbf1 mutants and similar to stage 14 wild type embryos, RnrS expression and BrdU
incorporation were seen only in the central midgut of maternal and zygotic PP187B1
mutants (Figure 3.4F, arrow), zygotic PP187B-PP196A double mutant embryos (Figure
3.4G, arrow), and zygotic PP113C; PP187B-PP196A triple mutant embryos (see
methods). In an attempt to remove all PP1 function in the midgut, we drove the expression
of UAS-HA NIPP1Dm with a midgut-specific driver and found that there was no
inappropriate expression of RnrS or ectopic BrdU incorporation in the anterior and posterior
midgut (Figure 3.4H, double arrow). Therefore, similar to what we observed during G1 cell
cycle exit in the epidermis, these data suggest that Rbf1 activity is regulated properly in
endocycling embryonic midgut cells in the absence of PP1 function.
p27Dap regulates embryonic midgut endocycles
The oscillation of CycE/Cdk2 activity is required for repeated rounds of endocycle S
phase in Drosophila (Lilly and Duronio, 2005). The induction of CycE/Cdk2 activity is
required to trigger DNA synthesis during S phase (Knoblich et al., 1994) while the
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termination of CycE/Cdk2 activity is needed for the assembly of new replication origins
during the endocycle gap phase (Sauer et al., 1995; Weiss et al., 1998). CycE/Cdk2 activity
oscillation is accomplished in part by the periodic expression of p27Dap, which is necessary
for normal endocycle regulation (de Nooij et al., 2000; Hong et al., 2003; Hong et al., 2007).
To test if p27Dap modulates Rbf1 activity in a cycling population of cells, we analyzed
RnrS expression and BrdU incorporation in the endocycling midgut of p27Dap-mutant
embryos. Similar to what was observed in a Rbf1-mutant embryo, there was both ectopic
RnrS expression and BrdU incorporation throughout the midgut rather than just in the central
midgut as in wild type embryos (compare Figure 3.4I to 3.4A). This result is consistent with
a model whereby p27Dap contributes to the control of E2f1 activity in endocycling cells via
regulating the state of Rbf1 phosphorylation. p27Dap also plays a more direct role in
controlling replication origin licensing in the endocycle, especially in the ovary (Hong et al.,
2003; Hong et al., 2007).
To test if p27Dap and PP1 cooperate in Rbf1 regulation in the endocycling midgut, we
analyzed RnrS expression and BrdU incorporation in the midgut of germ band-retracted,
p27Dap; PP187B double zygotic mutant embryos. There was ectopic RnrS expression and
BrdU incorporation throughout the midgut rather than just in the central midgut as seen in
wild type embryos (Figure 3.3B and Figure 3.4A). The phenotype of these double mutant
embryos was similar to, but not detectably worse than, p27Dap single mutants (Figure 3.4I),
suggesting that p27Dap and PP1 do not cooperate in controlling Rbf1 activity in this tissue.
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Type 1 protein phosphatases do not regulate Rbf1 activity in larval salivary glands
One interpretation of our failure to detect a replication or RnrS expression phenotype
in the embryo is that our genetic manipulations did not sufficiently reduce PP1 activity
because of an abundant maternal load of PP1 catalytic subunits. We therefore analyzed
larval stages of development when aberrant phenotypes arise in PP1 mutants (Axton et al.,
1990; Baksa et al., 1993). We chose to examine E2f1-target gene expression in endocycles
of the larval salivary gland, because Rbf1 activity is required in this tissue and because PP1
has an essential role during mitosis that precludes a careful analysis of E2f1 activity in
diploid cells (Axton et al., 1990). Without Rbf1, the entire salivary gland is smaller than
wild type and the oscillation of Cyclin E protein (and therefore CycE/Cdk2 activity) is lost
(Weng et al., 2003).
To test if PP1 regulates Rbf1 activity during the larval endocycle, we analyzed Cyclin
E protein expression in PP187B-mutant salivary glands. Cyclin E is a known target of E2f1
in endocycling salivary gland cells (Weng et al., 2003), and Cyclin E protein accumulation
oscillates, being high during S phase and low during gap phase (Follette et al., 1998; Weiss et
al., 1998). We also used a PCNA-EmGFP reporter construct to monitor E2f1 activity. This
transgenic reporter accurately depicts E2f1-target gene expression in embryonic and larval
cell cycles (Figure 3.5).
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Figure 3.5: PCNA-EmGFP transgene expression in the embryo and larva reports E2f1 activity.
(A-I) PCNA-EmGFP embryos stained with anti-GFP antibodies (green). (A) Syncytial embryo showing the
maternal contribution of PCNA-EmGFP. (B) Stage 5, blastoderm. (C) Stage 6. (D) Stage 9. (E) Stage 10.
Asterisk marks epidermal expression. (F) Stage 11. Expression declines in the epidermis (asterisk) as these
cells arrest in G1. (G) Stage 13. PCNA-EmGFP is expressed in the mitotically dividing brain lobes (BL) and
ventral nerve cord (VNC), and in the endocycling hindgut (HG) and anterior and posterior midguts (AMG and
PMG, respectively). (H) Stage 14. PCNA-EmGFP is expressed in the VNC, as well as the endocycling central
midgut (CMG), malphigian tubules (MT), and anal pad (AP). (I) Stage 14. PCNA-EmGFP is expressed in the
VNC but not the G1-arrested epidermis (asterisk). (J) PCNA-EmGFP eye and antennal discs from third instar
larva stained with anti-GFP antibodies (green). PCNA-EmGFP is expressed in the asynchronously dividing
cells in the anterior region of the eye disc (arrow) and in the second mitotic wave (arrowhead). The lack of
expression between these two regions denotes the G1-arrested cells in the morphogenetic furrow. (K) PCNA-
EmGFP early third instar larval salivary gland stained with anti-GFP antibodies (green) and DAPI (blue).
PCNA-EmGFP is expressed in a subset of cells (arrow) because the endocycles are asynchronous. Scale bars
are 50µm.
The asynchrony of the endocycles in the salivary gland results in patterned cyclin E protein
and PCNA-EmGFP expression. In a wild type salivary gland, cells in gap phase contain no
Cyclin E protein or PCNA-GFP expression (Figure 3.6A, large arrow). Cells with high levels
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of both Cyclin E and PCNA-EmGFP expression (Figure 3.6A, small arrow) are likely in early
S phase, while cells with high Cyclin E but low PCNA-EmGFP expression likely represent
late S phase (Figure 3.6A, arrowhead). These patterns of Cyclin E protein and PCNA-
EmGFP expression were observed in PP187B mutant salivary glands (Figure 3.6B and C,
large and small arrows). There was no significant difference in the numbers of Cyclin E
(P=0.8) or PCNA-EmGFP (P=0.8) positive nuclei between wild type and PP1-mutant
salivary glands. This suggests that E2f1 was properly regulated during the salivary gland
endocycle in this mutant. We also analyzed Cyclin E protein expression after over-
expressing NIPP1 using a salivary gland-specific driver. This treatment results in small
salivary glands with disrupted morphology, suggesting that PP1 activity is necessary for
normal salivary gland development. Nonetheless, Cyclin E protein accumulation still
oscillated, suggesting that E2f1 activity was regulated (Figure 3.6D). Taken together, these
results suggest that Rbf1 regulation of E2f1 in the larval salivary gland is not dependent on
PP1.
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Figure 3.6: PP1 does not regulate Rbf1 activity in the larval salivary glands.
(A-D) Salivary glands from early third instar larvae. (A-C) Salivary glands were stained with anti-Cyclin E
(red), anti-GFP (green), and DAPI (blue). Scale bars are 50µm. (A) PCNA EmGFP. (B) PP187B1-PCNA
EmGFP/PP187B87Bg-3. (C) PP187B87Bg-6-PCNA EmGFP/Df (3R) Exel 6164. The large arrows (A-C) mark
cells with low levels of both Cyclin E and PCNA-EmGFP. The small arrows (A-C) denote cells with high
levels of both Cyclin E and PCNA-EmGFP while the arrowhead (A) identifies a cell with high levels of Cyclin
E but low levels of PCNA-EmGFP. (D) UAS HA-NIPP1Dm/AB1-Gal4 salivary glands were stained with anti-
Cyclin E (green) and DAPI (blue). Scale bar is 20µm.
Type 1 protein phosphatases regulate Cyclin E protein oscillations in ovarian nurse cell
nuclei
The Drosophila ovary serves as another tissue in which to study the possible
contribution of PP1 to gene expression during the endocycle. Each ovary consists of
approximately 16 ovarioles, egg chamber assembly lines that contain all developmental
stages of oogenesis. At the most anterior region of each ovariole is the germarium, a
specialized structure that contains both germ line (GSCs) and somatic stem cells (SSCs).
GSCs divide asymmetrically to produce a daughter stem cell and a cystoblast (Lin and
Spradling, 1997). The cystoblast undergoes four, synchronous mitotic divisions with
incomplete cytokinesis to produce a 16-cell cyst. Before exiting the germarium, the germ
line cyst is encapsulated by somatic follicle cells to create an egg chamber. One of the
sixteen cyst cells will adopt the oocyte fate while the remaining fifteen will adopt a nurse cell
fate. The nurse cells become highly polyploid through multiple endocycles to support the
growth of the oocyte (Swanhart et al., 2005).
Like the endocyling cells of the salivary gland, Cyclin E protein oscillations are
critical for the regulation of the endocycle in the nurse cells (Lilly and Duronio, 2005). To
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assess the role of both Rbf1 and PP1 in nurse cell endocycle control, we analyzed Cyclin E
protein expression in Rbf1 and PP187B-mutant egg chambers. Representative pictures of
wild type and PP187B-mutant egg chambers are shown in Figure 3.7A and 3.7B,
respectively. Because the nurse cell endocycles are asynchronous, Cyclin E accumulates in
only a subset of the nurse cells in any one egg chamber (arrows). We hypothesized that if
E2f1-regulated transcription was a major contributor to the oscillation of Cyclin E protein
accumulation, then in the absence of Rbf1-mediated repression we would observe more
cyclin E positive nurse cells than in wild type. In addition, we would observe a similar
phenomenon in PP1 mutants nurse cells if PP1 activity was necessary to generate hypo-
phosphorylated Rbf1. We quantified the number of Cyclin E positive nurse cell nuclei in
stage 8 wild type, Rbf1-mutant, and PP187B-mutant egg chambers and the results are
depicted in Figure 3.7C. The average number of Cyclin E positive nurse cell nuclei was
similar in wild type and Rbf1-mutant egg chambers (p<0.101). This indicates that Cyclin E
expression is not dependent on the Rbf1/E2f1 pathway in this tissue. However, there was
significantly more Cyclin E positive nurse cell nuclei in PP187B mutants compared to both
wild type (P<0.00005) and Rbf1-mutant (P<0.006) egg chambers, suggesting that Cyclin E
protein oscillations are disrupted in PP187B-mutant egg chambers. These data are
consistent with a Rbf1-independent role for PP1 in the regulation of the endocycle in the
ovarian nurse cells.
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Figure 3.7: PP187B regulates Cyclin E protein oscillations in nurse cell endocycles.
(A-B) Stage 8 egg chambers were stained with anti-Cyclin E (red), phalloidin (green), and DAPI (blue).
Phalloidin, which stains f-actin, was used to outline the nurse cells and DAPI was used to mark nurse cell
nuclei. (A) w1118. The arrow denotes Cyclin E staining in a nurse cell. Cyclin E also accumulates to high levels
in the oocyte nucleus (arrowhead). (B) PP187B1 germ line clone. Scale bars are 50µm. (C) Quantification of
the number of Cyclin E positive nurse cell nuclei in stage 8 egg chambers of w1118, Rbf114 germ line clones and
PP187B1 germ line clones.
Discussion
pRb phosphorylation has an established role in controlling the activity of E2F
transcription factors during the cell cycle, particularly at the G1-S transition, and this
mechanism of cell cycle regulation is well-conserved (Cobrinik, 2005). In this work, we
used genetic analyses and the well-described cell cycle programs of Drosophila development
to ask whether type 1 protein phosphatases contribute to Rbf1/E2f1 regulation in several
tissues. We hypothesized that PP1 may be necessary for Rbf1 repressor activity from
mammalian data suggesting that PP1 is required for the dephosphorylation of pRb during
mitosis (Ludlow et al., 1993; Nelson et al., 1997; Nelson and Ludlow, 1997; Rubin et al.,
2001; Yan and Mumby, 1999). Using the expression of E2f1 targets as a readout, we found
no evidence that PP1 is necessary for Rbf1 activity during G1 arrest in the embryonic
epidermis and during the embryonic midgut, larval salivary gland, and ovarian nurse cell
endocycles. Since we cannot be absolutely certain that PP1 function was completely
eliminated by our genetic manipulations, it is possible that a small amount of PP1 activity
could dephosphorylate and thus activate Rbf1. We were also unable to detect a physical
interaction between PP187B and Rbf1 by co-immunoprecipitation experiments with
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embryonic extracts (Fig 3.8). We conclude that either another phosphatase is
Figure 3.8: PP187B does not physically associate with Rbf1.
UAS HA-PP187B was immuno-precipitated from either w1118 or UAS HA-PP187B/TM3 x actin-
Gal4/TM6B embryo extracts and the IPs were probed for the presence of Rbf1 by western blotting. (A) 0-8 Hr
w1118 supernatant. (B) 0-8 Hr w1118 IP. (C) 8-16 Hr w1118 supernatant. (D) 8-16 Hr w1118 IP. (E) 0-8 Hr UAS
HA-PP187B/TM3 x actin-Gal4/TM6B supernatant. (F) 0-8 Hr UAS HA-PP187B/TM3 x actin-Gal4/TM6B
IP. (G) 8-16 Hr UAS HA-PP187B/TM3 x actin-Gal4/TM6B supernatant. (H) 8-16 Hr UAS HA-
PP187B/TM3 x actin-Gal4/TM6B IP.
involved in the dephosphorylation of Rbf1, or that it acts redundantly with PP1. Along with
PP1, there is some evidence in mammalian cell lines that PP2A regulates the phosphorylation
status of pRb (Garriga et al., 2004).
Drosophila contain one other pRb and one other E2F family member, called Rbf2 and
E2f2, that function as part of a complex (MMB/dREAM) that controls the expression
(primarily via repression) of a large number of genes important for developmental processes
independent of the cell cycle (Dimova et al., 2003; Korenjak et al., 2004; Lewis et al., 2004;
Stevaux et al., 2002; Stevaux et al., 2005). Rbf1 appears to act redundantly with Rbf2 in this
complex. Although some data suggest that phosphorylation by G1 cyclin-dependent kinases
are insufficient to reverse E2f2-mediated repression (Frolov et al., 2003), it is possible that
PP1 could regulate the activity of Rbf2 or Rbf1 when bound to E2f2, and thus modulate the
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expression of MMB/dREAM target genes. This would provide a cell cycle-independent link
between PP1 and pRb family members that was not addressed by our experiments.
Our data show that Rbf1 is necessary for proper regulation of E2f1-target gene
expression and S phase in the endocycle of the embryonic midgut. In a Rbf1-mutant, cells of
the anterior and posterior midgut inappropriately replicate DNA and express RnrS at a time
when these cells should be in a gap phase (Du and Dyson, 1999). These results suggest that
Rbf1 is either necessary for exit from the endocycle S phase or required to maintain the
endocycle gap phase. We observed a similar phenotype in p27Dap mutants. Because p27Dap
protein oscillates during the endocycle (de Nooij et al., 2000), we suggest that any cycling
between hyper- and hypo-phosphorylated forms of Rbf1 (i.e. between S phase and gap
phase) may be controlled primarily by the presence or absence of this CycE/Cdk2 inhibitor,
rather than regulation of a phosphatase. Perturbing the oscillation of p27Dap protein disrupts
the normal oscillation of CycE/Cdk2 activity in the nurse cells of the ovary (Hong et al.,
2007).
Interestingly, PP1 may be required for the proper regulation of the endocycle in nurse
cells. We found more Cyclin E positive nurse cell nuclei in stage 8 PP187B-mutant egg
chambers compared to both wild type and Rbf1-mutant egg chambers, suggesting that the
oscillation of Cyclin E protein may be disrupted in this mutant. There is yeast two hybrid
data from Drosophila suggesting that PP187B physically interacts with Cdk2 (Stanyon et
al., 2004), and this interaction has also been described for one of the PP1 isoforms in
mammalian cell culture (Flores-Delgado et al., 2007). CycE/Cdk2 complexes may play an
important role in the turnover of Cyclin E protein during the endocycle (Lilly and Spradling,
1996). Through its interaction with Cdk2, PP1 could be directly involved in regulating
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Cyclin E protein levels during the nurse cell endocycle. Similar to E2f1 and Dp mutants
(Royzman et al., 2002), Cyclin E protein oscillations were not disrupted in Rbf1-mutant egg
chambers, suggesting that the contribution of E2f1-target gene expression to the regulation of
the nurse cell endocycle is minimal. This differs from endocycle control in the embryo
where E2f1-target gene expression is required for the proper timing of the endocycle
(Duronio et al., 1998), suggesting that endocycles may be modified by different regulatory
pathways in a tissue specific manner.
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CHAPTER IV
DISCUSSION AND FUTURE DIRECTIONS
The proper regulation of the cell cycle is an essential aspect of development in all
organisms. While focus is often placed on understanding how cells proliferate and the
driving forces behind this proliferation, it is equally important to understand how cells exit
the cycle. Since most cells exit the cell cycle in G1, the mechanisms that restrict entry into S
phase, including transcriptional repression of the E2F transcription factor by pRb and
inhibition of CycE/Cdk2 activity by p27, are particularly important. The Drosophila embryo
serves as a suitable model system in which to analyze the requirements for G1 arrest because
the timing of the first G1 has been well-characterized (Lee and Orr-Weaver, 2003). It is clear
that p27Dap inhibits the activity of CycE/Cdk2 and thus contributes to the initiation of G1
arrest in the embryonic epidermis (de Nooij et al., 1996; Lane et al., 1996). It has also been
established that Rbf1 restricts the expression of E2f1-target genes in these epidermal cells
and this is necessary to maintain G1 arrest in this tissue (Du and Dyson, 1999). However, the
mechanism contributing to the initial termination of E2f1-target gene expression remained
elusive. In this thesis, I have concluded that the regulated destruction of E2f1 protein during
S phase of cell cycles 15 and 16 contributes to the initial termination of target gene
expression, which surprisingly occurs independently of Rbf1. I have also concluded that the
activity of Rbf1 in the embryonic epidermis and midgut is regulated by phosphorylation.
The inhibition of CycE/Cdk2 by p27Dap and not the action of a type 1 protein phosphatase is
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responsible for the accumulation of the active, repressive form of Rbf1 in both tissues.
Do multiple mechanisms contribute to cell cycle exit and differentiation throughout
development?
In the embryonic epidermis, it is clear that both the inhibition of CycE/Cdk2 activity
by p27Dap and the inhibition of E2f1-target gene expression by Rbf1 are required for G1
arrest. At a time when p27Dap is no longer expressed in the epidermis, the removal of Rbf1
results in the inappropriate expression of E2f1-target genes such as CycE and RnrS and this
ultimately leads to some of the epidermal cells re-entering the cell cycle (de Nooij et al.,
1996; Du and Dyson, 1999; Lane et al., 1996). As CycE protein levels begin to accumulate,
active CycE/Cdk2 complexes are formed and can trigger entry into S phase, presumably
through the recruitment of MCM proteins to pre-RC complexes, because p27Dap is no longer
present to inhibit the activity of this complex, and because the levels of other essential
replication factors (i.e. RnrS, PCNA) have also accumulated in the absence of Rbf1.
Therefore, in order to drive the otherwise terminally differentiated cells of the embryonic
epidermis back into the cell cycle, the activities of both p27Dap and Rbf1 must be removed.
This mechanism of G1 arrest appears to be conserved throughout Drosophila development as
the actions of both p27Dap and Rbf1 are required for G1 arrest in the differentiating cell
populations of the eye and wing disc (Buttitta et al., 2007; Escudero and Freeman, 2007;
Firth and Baker, 2005).
Retinal development begins during the third larval instar in the eye imaginal disc.
There is a wave of differentiation that moves from the posterior of the disc towards the
anterior and is preceded by the morphogenetic furrow (MF). In the anterior of the disc, cells
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are dividing asynchronously and remain undifferentiated while posterior to the furrow,
ommatidial clusters begin to form and various cells of the adult retina are recruited from the
surrounding cells that remain undetermined. When cells enter the MF, they arrest in G1.
Those cells that form part of the precluster, including R2-5 and R8, remain arrested in G1.
The cells that have not joined a precluster undergo one final round of division before
differentiating into various surrounding cells (Baonza and Freeman, 2005). Maintenance of
G1 arrest in the precluster cells R2-5 is mediated by epidermal growth factor receptor
(EGFR) signaling. The EGFR pathway promotes the accumulation of p27Dap in these cells to
antagonize the high levels of CycE that are present (Firth and Baker, 2005). Rbf1 is also
active in the precluster cells and removal of either Rbf1 or p27Dap does not cause these cells
to re-enter the cell cycle (Firth and Baker, 2005). Rather, the removal of both Rbf1 and
p27Dap is required to disrupt G1 arrest in the precluster cells (Firth and Baker, 2005). This is
also true for cells within the MF that are not destined to become part of the precluster. The
dual mechanism of CycE/Cdk2 inhibition by p27Dap and the inhibition of E2f1 by Rbf1 is
required for G1 arrest in the anterior region of the furrow (Escudero and Freeman, 2007).
By twenty-four hours after pupa formation, all of the cells of the eye and the wing
epithelium have arrested in the G1 phase of the cell cycle (Buttitta et al., 2007). Similar to
the situation in the embryo and the eye imaginal disc, p27Dap and Rbf1 are each sufficient for
cell cycle exit in these differentiated cells since loss of either player alone does not result in
cells re-entering the cell cycle (Buttitta et al., 2007). Interestingly, cells in the pupal eye can
be driven back into the cell cycle by loss of p27Dap and the over-expression of E2f1 (to
override the activity of Rbf1) or by the loss of Rbf1 and the over-expression of CycE/Cdk2
(to override the activity of p27Dap) (Buttitta et al., 2007). However, this is not true for cells in
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the pupal wing suggesting that there is another layer of regulation that contributes to G1
arrest in this cell type (Buttitta et al., 2007).
Taken together, data describing G1 arrest in terminally-differentiated cells of the
embryonic epidermis, the larval and pupal eye as well as the pupal wing suggest that there is
a “double assurance mechanism” (Buttitta et al., 2007) controlling cell cycle exit throughout
development. Based on the known circuitry of the G1-S transition, one would expect the loss
of just Rbf1 or just p27Dap to disrupt G1 arrest. For example, if Rbf1 was eliminated from a
G1-arrested cell, this would result in the up-regulation of E2f1-target genes including CycE.
Accumulation of active CycE/Cdk2 complexes could possibly override the activity of p27Dap
and trigger entry into S phase. Likewise, if p27Dap was eliminated, active CycE/Cdk2
complexes would be free to phosphorylate Rbf1 and relieve the repression on E2f1 so that
target genes can be expressed and cells can enter S phase. However, this does not occur in
terminally-differentiated cells because of the robust mechanism promoting G1 arrest.
Interestingly, this “double assurance mechanism” may be evolutionarily conserved since
increasing E2F or Cyclin/Cdk activity alone cannot reverse cell cycle exit that is associated
with differentiation in mammalian systems (Camarda et al., 2004; Chandrasekaran et al.,
1996; Latella et al., 2001; Pajalunga et al., 1999; Sacco et al., 2003).
Mechanism of E2f1 protein degradation
In Chapter 2, my collaborator and I found that E2f1 protein was degraded during S
phase of cell cycles 15 and 16, and we concluded that this degradation contributed to the
initial termination of E2f1-target gene expression prior to the introduction of the first G1
during Drosophila embryogenesis. However, we do not know if this degradation is actually
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required for the termination of target gene expression. In order to address this, the
mechanism by which E2f1 is degraded in the Drosophila embryo must be elucidated.
Data from mammalian systems suggests that E2f1 (as well as E2f2 and E2f4) is a
relatively unstable protein and is degraded in a proteosome-dependent manner during S phase
(Campanero and Flemington, 1997; Hateboer et al., 1996; Hofmann et al., 1996). It was later
found that a SCF (Skp1-Cullin1-F-box) ubiquitin ligase, utilizing the F-box Skp2 (S-phase-
kinase-associated protein 2), was responsible for targeting E2f1 protein for degradation
(Marti et al., 1999), and regions in both the N-terminus and C-terminus of E2f1 were
required for its destruction (Campanero and Flemington, 1997; Hateboer et al., 1996;
Hofmann et al., 1996; Marti et al., 1999). The ubiquitin-proteosome pathway has also been
implicated in E2f1 destruction in Drosophila imaginal disc cells (Asano et al., 1996; Heriche
et al., 2003; Reis and Edgar, 2004). In these cells, E2f1 is destroyed at the G1-S transition by
a SCF complex utilizing the F-box slmb (slimb) (Heriche et al., 2003).
The SCF complex that targets E2f1 for proteolysis and the regions of E2f1 that are
required for its destruction in the embryo are currently unknown. To address this, it will be
useful to move to a Drosophila cell culture system where the destruction of E2f1 can be
easily monitored in a homogenous cell population. First, it will be necessary to determine
the pattern of E2f1 destruction in either Drosophila S2 or Dmel cells; i.e. if E2f1 is destroyed
just prior to or during S phase. If this occurs, truncation mutants of E2f1 can be created and
analyzed for their effect on E2f1 protein degradation. When the minimal region required for
E2f1 protein degradation has been determined, transgenic flies containing a stable form of
E2f1 can be created. Analyzing E2f1-target gene expression in early embryos where E2f1
cannot be degraded will allow us to address if the destruction of E2f1 protein is required for
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the initial termination of target gene expression. These experiments are currently being
performed by my collaborator, Shusaku Shibutani.
The identification of the SCF complex involved in the degradation of embryonic E2f1
protein can be accomplished in two different ways. First, candidate genes can be knocked
down using RNAi in a Drosophila cell culture system and the effects on E2f1 degradation
can be analyzed. Some of these candidate genes would include members of SCF E3
ubiquitin ligases such as Cullin 1, Slimb, and the Drosophila Skp2 ortholog. Once factors
involved in E2f1 protein degradation have been identified in cell culture, the effects of
mutation in these factors on E2f1 destruction in the embryo can be analyzed. Since the
destruction of E2f1 protein is seen during S phase of cell cycles 15 and 16, well after the start
of zygotic transcription, it is hypothesized that a zygotically-acting gene participates in E2f1
protein degradation. An alternative to searching for factors involved in E2f1 destruction in
cell culture would involve the screening of deficiency kits. Deficiency kits have been created
for each chromosome in Drosophila and contain a minimal number of stocks that provide
maximal coverage of the genome. Therefore, E2f1 protein destruction during S phase of cell
cycle 15 or 16 can be analyzed in each stock. If a particular stock disrupts E2f1 degradation,
the responsible gene can be identified by analyzing smaller deficiencies and candidate mutant
alleles.
While there has been considerable progress made on understanding how E2f1 protein
is regulated, less is known about the regulation of Dp protein, E2Fs binding partner. In
mammalian systems, Dp appears to be regulated post-translationally (Hateboer et al., 1996)
but when Dp is destroyed and by what mechanism is still unclear. It would be interesting to
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address whether Dp is also regulated post-translationally in Drosophila and whether Dp is
destroyed in a manner similar to E2f1.
Is E2f1 required for target gene expression in the early embryo?
The E2F transcription factor is required for the expression of genes necessary for S
phase, including RnrS, PCNA, and CycE (Duronio et al., 1998; Duronio et al., 1995;
Royzman et al., 1997). In germ band-retracted (cell cycles 17 and 18), zygotic E2f1-mutant
embryos, expression of both RnrS and PCNA is compromised in the mitotically dividing
central nervous system (CNS), the peripheral nervous system (PNS), and the epidermal cells
of the first thoracic segment as well as in the endodomains (Duronio et al., 1995; Royzman et
al., 1997). Interestingly, the expression of these replication factors is unaffected in germ
band-extended (cell cycles 14-16), zygotic E2f1-mutant embryos (Duronio et al., 1995), most
likely because maternal E2f1 protein is sufficient for this early expression. However, in
Chapter 2 my collaborator and I found that maternal E2f1 protein was not detectable in G2 of
cell cycle 14 in zygotic E2f1-mutant embryos. Therefore, E2f1 protein is not present in
E2f1-mutant embryos during cell cycles 15 and 16 yet E2f1-target gene expression appears to
be unaffected. This suggests that either maternal E2f1 protein is required during cell cycle
14 for the initial burst of E2f1-target gene expression or E2f1 is not required for the
expression of target genes in the early embryo.
Although there is an absence of data suggesting that E2f1 is required for the early
zygotic expression of target genes, there are data from our lab suggesting that E2f1 is
sufficient for the early expression of PCNA. There are two E2f1-binding sites in the
promoter of PCNA and a PCNA-GFP fusion construct containing these two binding sites can
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accurately reproduce the embryonic expression pattern of the PCNA gene (Thacker et al.,
2003). Along with this, mutation of both E2f1-binding sites eliminates both early and late
zygotic expression of PCNA (Thacker et al., 2003). This data supports a hypothesis where
E2f1 is required for the initial zygotic expression of target genes in the early embryo, and is
also required either alone or in combination with other factors to maintain this expression
through cell cycle 16 (Hirose et al., 1993; Sawado et al., 1998; Yamaguchi et al., 1996).
Alternatively, it is entirely possible that E2f1 is not required for the early expression
of target genes, although this is contrary to accepted dogma. For example, while E2f1 is
necessary for the expression of CycE in the embryonic endodomains, it is dispensable for
expression in the CNS (Duronio and O'Farrell, 1995; Jones et al., 2000). To test if E2f1 is
required for the early zygotic expression of target genes such as RnrS, PCNA, and CycE, it
will be necessary to remove both maternal and zygotic E2f1 (by generating E2f1 germ line
clones) and examine target gene expression in the early embryo (cell cycles 14-16). If E2f1
is required, then removal of E2f1 will result in the loss of zygotic target gene expression
while no effect on target gene expression suggests that E2f1 is not required. It is also
possible that E2f1 is required in combination with other factors, and the removal of E2f1 in
this situation may result in a reduction in target gene expression.
In Chapter 2, my collaborator and I showed that over-expression of an allele of Rbf1
that cannot be regulated by phosphorylation (UAS Rbf1-280; (Xin et al., 2002)) is capable of
precociously terminating E2f1-target gene expression in the early embryo (cell cycles 14-16).
This termination most likely involves the binding of Rbf1-280 to chromatin-bound E2f1,
however it also possible that this termination of target gene expression results from the
formation of ectopic repressor complexes independent of E2f1. To test if the presence of
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E2f1 is necessary for the precocious termination of target gene expression observed when
UAS Rbf1-280 is over-expressed, E2f1-target gene expression will be analyzed in zygotic
E2f1-mutant embryos that over-express UAS Rbf1-280. If target gene expression is not
terminated, it will suggest that Rbf1-280 must bind zygotic E2f1 in order to exert its effects
on expression. It would also support the contribution of E2f1 to target gene expression in the
early embryo because it implies that E2f1 is present at the promoters of these genes.
Is a phosphatase required to activate Rbf1 as a repressor of E2f1?
My collaborator and I have shown that prior to the introduction of the first G1 phase
during Drosophila embryogenesis, Rbf1 is converted from a hyper-phosphorylated form to a
hypo-phosphorylated form and is thus activated as a repressor of E2f1-target gene expression
(Chapter 2). Although this is not required for the initial termination of target gene expression
(Chapter 2), it is necessary for the continued repression of target genes in the G1-arrested
epidermis and for the proper timing of expression in the endocycling midgut (Du and Dyson,
1999). While p27Dap converts Rbf1 to a repressor in both the epidermis and midgut
(Chapters 2 and 3), I have concluded that PP1 does not participate in the activation of Rbf1 in
either tissue (Chapter 3). This was a surprising result because there is a fair amount of in
vitro and in vivo evidence from mammalian systems suggesting that PP1 dephosphorylates
pRb (Alberts et al., 1993; Ludlow et al., 1993; Nelson et al., 1997; Nelson and Ludlow, 1997;
Yan and Mumby, 1999). Therefore, the following question remains: is a phosphatase
involved in the dephosphorylation and thus activation of Rbf1 in Drosophila?
While my genetic evidence suggests that PP1 is not involved in the
dephosphorylation of Rbf1, it is still formally possible that I did not completely eliminate
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PP1 function in the tissues that were examined and therefore the remaining PP1 was
sufficient to dephosphorylate Rbf1. Alternatively, another phosphatase may be involved in
the dephosphorylation of Rbf1. To identify this phosphatase, it would be beneficial to move
into a Drosophila cell culture system where RNAi can be used to knock down multiple
family members at one time and thus combat redundancy between catalytic subunits. It
would also be useful to create a phospho-specific antibody to monitor the phosphorylation
status of Rbf1. Unlike mammalian pRb, the phospho-isoforms of Rbf1 cannot be
distinguished on SDS-PAGE gels. Using either Drosophila S2 or Dmel cells, single
phosphatase catalytic subunits or a combination of multiple catalytic subunits can be knocked
down by RNAi and the levels of hyper-phosphorylated Rbf1 in these cells analyzed. I would
hypothesize that if a phosphatase was involved in the dephosphorylation of Rbf1 then
knocking down this phosphatase would result in the accumulation of hyper-phosphorylated
Rbf1. Once the putative Rbf1 phosphatase (or phosphatases) has been identified, it will be
necessary to generate mutant animals to determine if this phosphatase(s) promotes the
conversion of Rbf1 to a repressor of E2f1-target gene expression in the embryonic epidermis
and midgut.
It is equally possible that a phosphatase is not involved in the dephosphorylation of
Rbf1. If the synthesis and proteolytic turnover of Rbf1 is rapid enough, then the down-
regulation of CycE/Cdk2 activity by p27Dap would allow for hypo-phosphorylated Rbf1 to
accumulate while any hyper-phosphorylated Rbf1 is destroyed. While there are no data
regarding the stability of Rbf1 protein during Drosophila embryogenesis, there is some data
from Drosophila S2 cells. Rbf1 protein levels were examined following treatment with
cycloheximide, an inhibitor of protein synthesis. After one hour, Rbf1 protein could not be
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detected by Western blot suggesting that this protein is highly unstable (Ullah et al., 2007).
If Rbf1 protein is equally unstable in the embryo, then a reasonable mechanism for the
accumulation of hypo-phosphorylated Rbf1 would involve p27Dap but not a phosphatase.
This would be true in both the epidermis and the midgut. Since the cell cycles in the
postblastoderm embryo are at least one hour in length (Foe, 1989) and S phase in the
endocycling midgut measures approximately eighty minutes (R. Duronio, personal
communication), there is enough time to degrade hyper-phosphorylated Rbf1 so that hypo-
phosphorylated Rbf1 can accumulate in the G1-arrested epidermis or in G1 of the endocycle.
To test if the destruction of hyper-phosphorylated Rbf1 contributes to the accumulation of
hypo-phosphorylated Rbf1, a stable form of this protein should be created. I hypothesize that
expression of a stable form of Rbf1 protein during embryogenesis would disrupt both the
continued repression of E2f1-target genes in the G1-arrested epidermis as well as the timing
of target gene expression in the endocycling midgut, resulting in a phenotype similar to what
has been observed in Rbf1-mutant embryos.
If the destruction of hyper-phosphorylated Rbf1 contributes to the accumulation of
active, hypo-phosphorylated Rbf1during embryogenesis, it would be interesting to describe
the mechanism by which hyper-phosphorylated Rbf1 is destroyed. Evidence from
Drosophila S2 cells suggests that Rbf1 can be degraded by a proteosome-dependent pathway
(Ullah et al., 2007) and there is data from mammalian systems that SCFSkp2, an E3 ubiquitin
ligase, contributes to the destruction of the pRb-related protein p130 (Tedesco et al., 2002).
To identify the components of the E3 ubiquitin ligase involved in Rbf1 destruction, RNAi
can be used to knock down members of various E3 ubiquitin ligases in S2 cells and the
accumulation of hyper-phosphorylated Rbf1 can be measured using a phospho-specific
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antibody. If this candidate gene approach is not fruitful, a genome-wide RNAi screen can be
implemented to identify remaining components. Once these factors have been identified, it
would be interesting to analyze E2f1-target gene expression in mutant animals. If hyper-
phosphorylated Rbf1 cannot be destroyed then these mutants should phenocopy both Rbf1-
mutants as well as animals where a non-degradable form of Rbf1 is expressed.
Mechanism of p27Dap degradation
The epidermal cells in a p27Dap-mutant embryo fail to arrest in G1 of cycle 17 and
inappropriately enter an ectopic S phase (de Nooij et al., 1996; Lane et al., 1996). This
striking phenotype is shared by only one other mutant in Drosophila. An ectopic S phase
during cycle 17 is also seen in the epidermis of fzr mutants but the reason for this has
remained unclear (Sigrist and Lehner, 1997). fzr encodes Drosophila Cdh1, which targets
mitotic cyclins for ubiquitination and destruction by the APC/C during G1 (Jacobs et al.,
2002; Sigrist and Lehner, 1997). The ectopic S phase seen in the epidermis of fzr mutants is
not Cyclin A-dependent (Sigrist and Lehner, 1997), therefore it is reasonable to hypothesize
that this phenotype results from unregulated CycE/Cdk2 activity, which is required for S
phase in Drosophila (Knoblich et al., 1994). This leads to the following question: why is
there unregulated CycE/Cdk2 activity in fzr mutants? The answer may lie in the cyclin
dependent kinase inhibitor, p27Dap.
In mammalian systems, the levels of p27 protein are tightly regulated throughout the
cell cycle. The highest levels of p27 are found when cells are in G0 and G1, and this protein
is destroyed as cells transition into S phase (Bashir and Pagano, 2004). The SCFSkp2
ubiquitin ligase is responsible for the ubiquitination and subsequent proteosomal degradation
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of p27 (Carrano et al., 1999; Sutterluty et al., 1999). This destruction is dependent on the
phosphorylation of p27 at threonine 187 by CycE/Cdk2 complexes (Malek et al., 2001;
Sheaff et al., 1997; Tsvetkov et al., 1999) and requires the accessory factor Cks1 (Cdc kinase
subunit 1) (Ganoth et al., 2001; Spruck et al., 2001). Interestingly, the protein levels of both
Skp2 and Cks1 are also cell cycle-regulated. They are found at low levels during G0 and G1
but accumulate as cells transition from G1 to S phase (Bashir et al., 2004). Thus, there is an
inverse correlation between p27 protein levels and both Skp2 and Cks1 protein levels.
Recently, it has been shown that the APC/CCdh1 targets both Skp2 and Cks1 for degradation
during G1, and this not only prevents the premature degradation of p27 but is also required
for the maintenance of the G1 state (Bashir et al., 2004; Wei et al., 2004).
In the Drosophila embryo, p27Dap has a dynamic expression pattern whereby this
protein accumulates in cells as they are completing their final divisions. For example, p27Dap
is up-regulated in the epidermis just prior to G1 arrest during cell cycle 17 but then becomes
restricted to the peripheral and central nervous systems in the next cell cycle (de Nooij et al.,
1996; Lane et al., 1996). The transient expression of p27Dap suggests that this protein is
regulated post-translationally, possibly by the ubiquitin-proteosome pathway. There is some
evidence in S2 cells that Cullin 4 (Cul4)-containing SCF E3 ubiquitin ligases regulate p27Dap
protein levels (Higa et al., 2006). It would be interesting to determine if this is also true in
the embryo and if other SCF complexes, particularly SCFSkp2, are involved in regulating the
levels of this protein (Figure 4.1). The gene CG9772 is the Drosophila ortholog of human
Skp2, sharing 54% similarity and 31% identity with its mammalian counterpart (Moberg et
al., 2004). There are no reported mutant alleles of CG9772Skp2 however RNAi constructs are
available to target this gene (Moberg et al., 2004) and there is a P element upstream of the
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translation start site that could serve as a possible mutant or could be excised imprecisely to
create a mutant allele (Drosophila P element database, Baylor University). Once a mutant is
available, the pattern of p27Dap expression can be analyzed. If CG9772Skp2 is involved in the
destruction of p27Dap, then I would expect p27Dap protein to persist in the epidermis after
cycle 17 when it normally would be down-regulated in this tissue. There is also a putative
Drosophila ortholog of mammalian Cks1, the accessory factor required for p27 degradation.
This gene is encoded by Cks85A and there is one mutant allele available: a piggyBac
transposable element inserted shortly after the transcription start site (Flybase). It would also
be interesting to analyze the pattern of p27Dap protein in this mutant to determine if all of the
factors involved in the destruction of p27 in mammalians systems are conserved in
Drosophila.
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Figure 4.1: Mechanism of p27 protein degradation in mammals and possible mechanism for p27Dacapo
protein degradation in Drosophila.
(Top; Left) During G1, the APC/C along with its specificity factor Cdh1 is responsible for the destruction of
both Skp2 and Cks1, two components of an SCF complex that targets p27 for degradation. This results in the
accumulation of p27 protein and participates in the maintenance of the G1 state. (Top; Right) During S phase,
the APC/C becomes inactivated which results in the accumulation of Skp2 and Cks1 and the formation of active
SCFSkp2 E3 ubiquitin ligases. These complexes subsequently target p27 protein for destruction by the 26S
proteosome. (Bottom; Left) A similar mechanism may act to protect p27Dap protein from destruction prior to
the introduction of the first G1 during embryogenesis. (Bottom; Right) A SCFSkp2 E3 ubiquitin ligase may
regulate p27Dap protein stability during Drosophila development.
Since mammalian APC/CCdh1 prevents the premature degradation of p27 in G1 by
targeting Skp2 and Cks1 for destruction, it is possible that this “protective mechanism” also
exists in Drosophila and allows for the accumulation of p27Dap in the epidermis just prior to
the introduction of G1 during cell cycle 17. Interestingly, fzr mRNA is up-regulated in the
epidermis at the same time that p27Dap expression is up-regulated in this tissue (de Nooij et
al., 1996; Lane et al., 1996; Sigrist and Lehner, 1997). Assuming that SCFCG9772/Cks85A is
involved in the degradation of p27Dap and that the APC/Cfzr targets Skp2 and possibly
Cks85A for ubiquitin-mediated proteolysis, the ectopic S phase seen in the epidermis of fzr-
mutant embryos may result from unrestricted CycE/Cdk2 activity because of the premature
degradation of p27Dap protein (or the failure of this protein to accumulate). If this is the case,
then p27Dap protein should either not accumulate or be found at very low levels in the
epidermis of fzr-mutant embryos just prior to the introduction of G1.
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Concluding Remarks
The work described in this thesis has contributed to our understanding of the
mechanisms involved in G1 arrest in the Drosophila embryo. We have discovered that the
initial termination of E2f1-target gene expression involves the destruction of the
transcriptional activator E2f1 rather than the activation of the transcriptional repressor Rbf1,
thus identifying another way to regulate embryonic E2f1 activity. We have also learned
more about the regulation of Rbf1 activity in the embryo. Although it is not surprising that
Rbf1 is controlled by phosphorylation, it is interesting that a phosphatase is not involved in
the activation of Rbf1 in G1-arrested as well as endocycling cells. By analyzing a very
specific time in development, namely the introduction of the first G1, we have been able to
fine-tune our understanding of how important cell cycle regulators are controlled during
development.
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